BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 429179 CC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246096 US10183932, Example 1::US9434690, 1::US9822102, Example 1 Coagulation factor XI Homo sapiens 53 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246096&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622715 341103945 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429180 COCc1n[nH]c(n1)-c1ccc(NC(=O)C(C)n2ccc(cc2=O)-c2cc(Cl)ccc2C#N)cc1 246098 US9434690, 3::US9822102, Example 3 Coagulation factor XI Homo sapiens 430 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246098&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877955 341103947 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429181 CC(C(=O)Nc1ccc(cc1)-c1c[nH]cn1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246100 US10183932, Example 5::US9434690, 5::US9822102, Example 5 Coagulation factor XI Homo sapiens 150 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246100&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297545 341103949 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429182 CC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H16ClN5O3/c1-14(24(33)27-19-6-3-15(4-7-19)21-12-22(31)29-28-21)30-9-8-16(10-23(30)32)20-11-18(25)5-2-17(20)13-26/h2-12,14H,1H3,(H,27,33) MHOPKDGSPNBRDE-UHFFFAOYSA-N 246102 US10183932, Example 7::US9434690, 7::US9822102, Example 7 Coagulation factor XI Homo sapiens 82 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246102&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626901 341103951 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429183 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H16ClN3O4/c1-13(21(28)25-18-6-3-14(4-7-18)22(29)30)26-9-8-15(10-20(26)27)19-11-17(23)5-2-16(19)12-24/h2-11,13H,1H3,(H,25,28)(H,29,30) IVAMXDIDNRHTRD-UHFFFAOYSA-N 246104 US10183932, Example 9::US9434690, 9::US9822102, Example 9 Coagulation factor XI Homo sapiens 170 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246104&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622737 341103953 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429184 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1ccc(cc1=O)-c1cc(Cl)ccc1Cl InChI=1S/C21H16Cl2N2O4/c1-12(20(27)24-16-5-2-13(3-6-16)21(28)29)25-9-8-14(10-19(25)26)17-11-15(22)4-7-18(17)23/h2-12H,1H3,(H,24,27)(H,28,29) CZMAYQRSFWUMLN-UHFFFAOYSA-N 246106 US10183932, Example 11::US9434690, 11::US9822102, Example 11 Coagulation factor XI Homo sapiens 750 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246106&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297341 341103955 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429185 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C(F)(F)F InChI=1S/C22H16ClF3N2O4/c1-12(20(30)27-16-5-2-13(3-6-16)21(31)32)28-9-8-14(10-19(28)29)17-11-15(23)4-7-18(17)22(24,25)26/h2-12H,1H3,(H,27,30)(H,31,32) OEDFEYUZHDDGRU-UHFFFAOYSA-N 246108 US10183932, Example 13::US9434690, 13::US9822102, Example 13 Coagulation factor XI Homo sapiens 600 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246108&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622934 341103957 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429186 CC(C(=O)Nc1ccc(C(O)=O)c(Cl)c1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-4-5-17(22(30)31)19(24)10-16)27-7-6-13(8-20(27)28)18-9-15(23)3-2-14(18)11-25/h2-10,12H,1H3,(H,26,29)(H,30,31) BAMOPYCKXHHTCG-UHFFFAOYSA-N 246110 US10183932, Example 15::US9434690, 15::US9822102, Example 15 Coagulation factor XI Homo sapiens 430 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246110&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622603 341103959 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429187 CC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246112 US10183932, Example 17::US9434690, 17::US9822102, Example 17 Coagulation factor XI Homo sapiens 960 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246112&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626903 341103961 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429188 CCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246114 US10183932, Example 21::US9434690, 19::US9434690, 20::US9434690, 21::US9822102, Example 21 Coagulation factor XI Homo sapiens 59 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246114&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622611 341103963 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429189 CCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246114 US10183932, Example 21::US9434690, 19::US9434690, 20::US9434690, 21::US9822102, Example 21 Coagulation factor XI Homo sapiens 26 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246114&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622611 341103963 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429190 CCCCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246118 US10183932, Example 23::US9434690, 23::US9822102, Example 23 Coagulation factor XI Homo sapiens 150 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246118&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622898 341103965 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429191 OC(=O)c1ccc(NC(=O)C(CC2CC2)n2ccc(cc2=O)-c2cc(Cl)ccc2OC(F)(F)F)cc1 InChI=1S/C25H20ClF3N2O5/c26-17-5-8-21(36-25(27,28)29)19(13-17)16-9-10-31(22(32)12-16)20(11-14-1-2-14)23(33)30-18-6-3-15(4-7-18)24(34)35/h3-10,12-14,20H,1-2,11H2,(H,30,33)(H,34,35) GEYVYCQVRWAJKJ-UHFFFAOYSA-N 246120 US10183932, Example 25::US9434690, 25::US9822102, Example 25 Coagulation factor XI Homo sapiens 220 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246120&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297542 341103967 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429192 OC(=O)c1ccc(NC(=O)C(Cc2ccccn2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-18-6-9-22(27(29,30)31)21(14-18)17-10-12-34(24(35)13-17)23(15-20-3-1-2-11-32-20)25(36)33-19-7-4-16(5-8-19)26(37)38/h1-14,23H,15H2,(H,33,36)(H,37,38) CKFCLGOBAUZLCA-UHFFFAOYSA-N 246122 US10183932, Example 27::US9434690, 27::US9822102, Example 27 Coagulation factor XI Homo sapiens 42 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246122&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622905 341103969 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429193 OC(=O)c1ccc(NC(=O)C(Cc2cccnc2)n2ccc(cc2=O)-c2cc(Cl)ccc2Br)cc1 InChI=1S/C26H19BrClN3O4/c27-22-8-5-19(28)14-21(22)18-9-11-31(24(32)13-18)23(12-16-2-1-10-29-15-16)25(33)30-20-6-3-17(4-7-20)26(34)35/h1-11,13-15,23H,12H2,(H,30,33)(H,34,35) FJLLPUNDAQQFCD-UHFFFAOYSA-N 246124 US10183932, Example 29::US9434690, 29::US9822102, Example 29 Coagulation factor XI Homo sapiens 36 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246124&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622939 341103971 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429194 OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38) VOEMZDCOWSMTBH-UHFFFAOYSA-N 246125 US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32 Coagulation factor XI Homo sapiens 24000 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622752 341103972 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429195 OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2Br)cc1 InChI=1S/C26H19BrClN3O4/c27-22-6-3-19(28)15-21(22)18-9-12-31(24(32)14-18)23(13-16-7-10-29-11-8-16)25(33)30-20-4-1-17(2-5-20)26(34)35/h1-12,14-15,23H,13H2,(H,30,33)(H,34,35) NBSDLGUPVWYUGD-UHFFFAOYSA-N 246128 US10183932, Example 33::US9434690, 33::US9822102, Example 33 Coagulation factor XI Homo sapiens 33 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246128&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622617 341103973 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429196 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31) MYLKJUSMRUADNT-UHFFFAOYSA-N 246130 US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37 Coagulation factor XI Homo sapiens 27 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622690 341103975 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429197 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31) MYLKJUSMRUADNT-UHFFFAOYSA-N 246130 US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37 Coagulation factor XI Homo sapiens 14 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622690 341103975 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429198 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C(F)(F)F InChI=1S/C22H15Cl2F3N2O4/c1-11(20(31)28-14-5-2-12(3-6-14)21(32)33)29-10-18(24)16(9-19(29)30)15-8-13(23)4-7-17(15)22(25,26)27/h2-11H,1H3,(H,28,31)(H,32,33) JCQMXNRUWUGMIH-UHFFFAOYSA-N 246134 US10183932, Example 39::US9434690, 39::US9822102, Example 39 Coagulation factor XI Homo sapiens 1100 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246134&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622990 341103977 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429199 CC(C(=O)Nc1ccc(cc1)-c1nc(n[nH]1)C(F)(F)F)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N 246136 US10183932, Example 41::US9434690, 41::US9822102, Example 41 Coagulation factor XI Homo sapiens 54 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246136&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622989 341103979 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429200 CC(C(=O)Nc1ccc(cc1)-c1cnc[nH]1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N 246138 US10183932, Example 43::US9434690, 43::US9822102, Example 43 Coagulation factor XI Homo sapiens 40 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246138&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622610 341103981 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429201 OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34) APZJTXHPPDAWRM-UHFFFAOYSA-N 246140 US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47 Coagulation factor XI Homo sapiens 13 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622732 341103983 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429202 OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34) APZJTXHPPDAWRM-UHFFFAOYSA-N 246140 US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47 Coagulation factor XI Homo sapiens 9.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622732 341103983 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429203 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(C#N)c(cc1=O)-c1cc(Cl)ccc1C(F)F InChI=1S/C23H16ClF2N3O4/c1-12(22(31)28-16-5-2-13(3-6-16)23(32)33)29-11-14(10-27)18(9-20(29)30)19-8-15(24)4-7-17(19)21(25)26/h2-9,11-12,21H,1H3,(H,28,31)(H,32,33) QSRLRSJHSYLVHH-UHFFFAOYSA-N 246144 US10183932, Example 49::US9434690, 49::US9822102, Example 49 Coagulation factor XI Homo sapiens 43 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246144&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622615 341103985 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429204 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(C#N)c(cc1=O)-c1cc(Cl)ccc1OC(F)(F)F InChI=1S/C23H15ClF3N3O5/c1-12(21(32)29-16-5-2-13(3-6-16)22(33)34)30-11-14(10-28)17(9-20(30)31)18-8-15(24)4-7-19(18)35-23(25,26)27/h2-9,11-12H,1H3,(H,29,32)(H,33,34) QLPHQTBYWTUCHR-UHFFFAOYSA-N 246146 US10183932, Example 51::US9434690, 51::US9822102, Example 51 Coagulation factor XI Homo sapiens 500 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246146&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622912 341103987 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429205 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(C(F)F)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C23H16ClF2N3O4/c1-12(22(31)28-16-6-3-13(4-7-16)23(32)33)29-11-19(21(25)26)18(9-20(29)30)17-8-15(24)5-2-14(17)10-27/h2-9,11-12,21H,1H3,(H,28,31)(H,32,33) SDGTVFLLMIACAE-UHFFFAOYSA-N 246148 US10183932, Example 53::US9434690, 53::US9822102, Example 53 Coagulation factor XI Homo sapiens 630 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246148&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622991 341103989 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429206 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31) MPSQYCLTAAEIDL-UHFFFAOYSA-N 246150 US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57 Coagulation factor XI Homo sapiens 5.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622624 341103991 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429207 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31) MPSQYCLTAAEIDL-UHFFFAOYSA-N 246150 US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57 Coagulation factor XI Homo sapiens 2.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622624 341103991 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429208 COc1cn(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H22ClN3O5/c1-35-23-14-30(24(31)12-21(23)20-11-18(27)7-4-17(20)13-28)22(10-15-2-3-15)25(32)29-19-8-5-16(6-9-19)26(33)34/h4-9,11-12,14-15,22H,2-3,10H2,1H3,(H,29,32)(H,33,34) YEOQEAASRZWJNV-UHFFFAOYSA-N 246154 US10183932, Example 60::US9434690, 59::US9434690, 60::US9822102, Example 60 Coagulation factor XI Homo sapiens 950 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246154&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622901 341103993 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429209 COc1cn(C(CC#C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H18ClN3O5/c1-3-4-21(24(31)28-18-9-6-15(7-10-18)25(32)33)29-14-22(34-2)20(12-23(29)30)19-11-17(26)8-5-16(19)13-27/h1,5-12,14,21H,4H2,2H3,(H,28,31)(H,32,33) BVJKTUAUDCSIJC-UHFFFAOYSA-N 246156 US10183932, Example 61::US9434690, 61::US9822102, Example 61 Coagulation factor XI Homo sapiens 4.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246156&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622828 341103994 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429210 COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34) PDLAMRDOLIUATC-UHFFFAOYSA-N 246158 US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65 Coagulation factor XI Homo sapiens 9.1 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622627 341103996 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429211 COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34) PDLAMRDOLIUATC-UHFFFAOYSA-N 246158 US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65 Coagulation factor XI Homo sapiens 4.7 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622627 341103996 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429212 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32) HUXWVMXMMHUYLB-UHFFFAOYSA-N 246161 US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140 Coagulation factor XI Homo sapiens 1700 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622754 341103997 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429213 CCC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H20ClN5O4/c1-3-22(26(35)29-18-8-5-15(6-9-18)21-12-24(33)31-30-21)32-14-23(36-2)20(11-25(32)34)19-10-17(27)7-4-16(19)13-28/h4-12,14,22H,3H2,1-2H3,(H,29,35) UBQSSKXXBQWBRF-UHFFFAOYSA-N 246164 US10183932, Example 69::US9434690, 69::US9822102, Example 69 Coagulation factor XI Homo sapiens 3.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246164&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626907 341103998 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429214 CCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClN5O4/c1-3-20(23(32)27-15-6-7-18-19(9-15)29-24(33)28-18)30-12-21(34-2)17(10-22(30)31)16-8-14(25)5-4-13(16)11-26/h4-10,12,20H,3H2,1-2H3,(H,27,32) MYCQSHUBJLXZMN-UHFFFAOYSA-N 246166 US10183932, Example 71::US9434690, 71::US9822102, Example 71 Coagulation factor XI Homo sapiens 32 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246166&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626909 341104000 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429215 CCC(C(=O)Nc1ccc2nc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246168 US10183932, Example 73::US9434690, 73::US9822102, Example 73 Coagulation factor XI Homo sapiens 6.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246168&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622919 341104002 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429216 CCC(C(=O)Nc1ccc2[nH]c(cc2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246170 US10183932, Example 75::US9434690, 75::US9822102, Example 75 Coagulation factor XI Homo sapiens 4.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246170&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622951 341104004 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429217 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33) XAYFQGTYMRMPAS-UHFFFAOYSA-N 246171 US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78 Coagulation factor XI Homo sapiens 2000 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297748 341104005 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429218 CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1 DYNSAJCVHKUDFF-UEDXYCIISA-N 246174 US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81 Coagulation factor XI Homo sapiens 3.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877945 341104006 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429219 CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1 DYNSAJCVHKUDFF-UEDXYCIISA-N 246174 US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81 Coagulation factor XI Homo sapiens 0.7 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877945 341104006 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429220 CO[C@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m1/s1 DYNSAJCVHKUDFF-JGHKVMFLSA-N 246177 US10183932, Example 83::US9434690, 82::US9434690, 83::US9822102, Example 83 Coagulation factor XI Homo sapiens 5.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246177&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877889 341104007 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429221 COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1 AETBCOOBUYAHJM-PPUHSXQSSA-N 246179 US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86 Coagulation factor XI Homo sapiens 1900 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622620 341104008 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429222 COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1 AETBCOOBUYAHJM-AJZOCDQUSA-N 246182 US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89 Coagulation factor XI Homo sapiens 2.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877947 341104009 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429223 COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1 AETBCOOBUYAHJM-AJZOCDQUSA-N 246182 US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89 Coagulation factor XI Homo sapiens 75 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877947 341104009 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429224 COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35) UPJPTNTVAMVKSD-UHFFFAOYSA-N 246185 US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93 Coagulation factor XI Homo sapiens 470 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297749 341104010 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429225 COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35) UPJPTNTVAMVKSD-UHFFFAOYSA-N 246185 US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93 Coagulation factor XI Homo sapiens 4.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297749 341104010 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429226 COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36) BMRPDPXXIHCBMO-UHFFFAOYSA-N 246189 US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96 Coagulation factor XI Homo sapiens 520 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297750 341104011 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429227 COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36) SNVIVXDTJLCEGY-UHFFFAOYSA-N 246192 US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100 Coagulation factor XI Homo sapiens 4.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622761 341104012 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429228 COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36) SNVIVXDTJLCEGY-UHFFFAOYSA-N 246192 US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100 Coagulation factor XI Homo sapiens 920 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622761 341104012 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429229 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Coagulation factor XI Homo sapiens 1.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429230 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Coagulation factor XI Homo sapiens 0.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429231 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Coagulation factor XI Homo sapiens 1.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429232 COc1cn(C(CCF)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-34-21-13-29(22(30)11-19(21)18-10-16(25)5-2-15(18)12-27)20(8-9-26)23(31)28-17-6-3-14(4-7-17)24(32)33/h2-7,10-11,13,20H,8-9H2,1H3,(H,28,31)(H,32,33) UUJSOQRGXUGTOX-UHFFFAOYSA-N 246202 US10183932, Example 107::US9434690, 107::US9822102, Example 107 Coagulation factor XI Homo sapiens 5.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246202&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297751 341104015 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429233 COc1cn(C(CC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H17ClF3N3O5/c1-36-20-12-31(21(32)9-18(20)17-8-15(25)5-2-14(17)11-29)19(10-24(26,27)28)22(33)30-16-6-3-13(4-7-16)23(34)35/h2-9,12,19H,10H2,1H3,(H,30,33)(H,34,35) JTNKIBBMWHFHLA-UHFFFAOYSA-N 246204 US10183932, Example 109::US9434690, 109::US9822102, Example 109 Coagulation factor XI Homo sapiens 31 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246204&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622628 341104017 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429234 COc1cn(C(CC(C)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H21ClF3N3O5/c1-14(26(28,29)30)9-21(24(35)32-18-7-4-15(5-8-18)25(36)37)33-13-22(38-2)20(11-23(33)34)19-10-17(27)6-3-16(19)12-31/h3-8,10-11,13-14,21H,9H2,1-2H3,(H,32,35)(H,36,37) BHOCMFJOQHDNNX-UHFFFAOYSA-N 246206 US10183932, Example 111::US9434690, 111::US9822102, Example 111 Coagulation factor XI Homo sapiens 34 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246206&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117623008 341104019 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429235 COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36) PPOMRFJZWPHFPA-UHFFFAOYSA-N 246208 US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115 Coagulation factor XI Homo sapiens 4.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297949 341104021 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429236 COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36) PPOMRFJZWPHFPA-UHFFFAOYSA-N 246208 US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115 Coagulation factor XI Homo sapiens 3.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297949 341104021 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429237 COc1cn(C(CC2CCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O5/c1-36-24-15-31(25(32)13-22(24)21-12-19(28)8-5-18(21)14-29)23(11-16-3-2-4-16)26(33)30-20-9-6-17(7-10-20)27(34)35/h5-10,12-13,15-16,23H,2-4,11H2,1H3,(H,30,33)(H,34,35) BXIDJSNINHKLLQ-UHFFFAOYSA-N 246212 US10183932, Example 117::US9434690, 117::US9822102, Example 117 Coagulation factor XI Homo sapiens 1.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246212&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297950 341104023 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429238 COc1cn(CC(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C22H16ClN3O5/c1-31-19-11-26(12-20(27)25-16-6-3-13(4-7-16)22(29)30)21(28)9-18(19)17-8-15(23)5-2-14(17)10-24/h2-9,11H,12H2,1H3,(H,25,27)(H,29,30) SAHCVGAZLPRNEE-UHFFFAOYSA-N 246214 US10183932, Example 119::US9434690, 119::US9822102, Example 119 Coagulation factor XI Homo sapiens 28 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246214&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622872 341104025 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429239 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1Br InChI=1S/C22H18BrClN2O5/c1-12(21(28)25-15-6-3-13(4-7-15)22(29)30)26-11-19(31-2)17(10-20(26)27)16-9-14(24)5-8-18(16)23/h3-12H,1-2H3,(H,25,28)(H,29,30) BZZDCJXMIRUBDL-UHFFFAOYSA-N 246216 US10183932, Example 121::US9434690, 121::US9822102, Example 121 Coagulation factor XI Homo sapiens 17 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246216&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297951 341104027 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429240 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C(F)(F)F InChI=1S/C23H18ClF3N2O5/c1-12(21(31)28-15-6-3-13(4-7-15)22(32)33)29-11-19(34-2)17(10-20(29)30)16-9-14(24)5-8-18(16)23(25,26)27/h3-12H,1-2H3,(H,28,31)(H,32,33) AHLPDNRPHFMHAO-UHFFFAOYSA-N 246218 US10183932, Example 123::US9434690, 123::US9822102, Example 123 Coagulation factor XI Homo sapiens 63 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246218&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622932 341104029 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429241 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Coagulation factor XI Homo sapiens 3.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429242 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C23H19ClF2N2O6/c1-12(21(30)27-15-6-3-13(4-7-15)22(31)32)28-11-19(33-2)17(10-20(28)29)16-9-14(24)5-8-18(16)34-23(25)26/h3-12,23H,1-2H3,(H,27,30)(H,31,32) YRKPZRMKWAQTNS-UHFFFAOYSA-N 246222 US10183932, Example 127::US9434690, 127::US9822102, Example 127 Coagulation factor XI Homo sapiens 10 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246222&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622893 341104033 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429243 CCOc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-33-21-13-28(14(2)23(30)27-18-8-5-15(6-9-18)24(31)32)22(29)11-20(21)19-10-17(25)7-4-16(19)12-26/h4-11,13-14H,3H2,1-2H3,(H,27,30)(H,31,32) MHLRUCJOXJQBOK-UHFFFAOYSA-N 246224 US10183932, Example 129::US9434690, 129::US9822102, Example 129 Coagulation factor XI Homo sapiens 24 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246224&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622947 341104035 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429244 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OCC(F)(F)F)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H17ClF3N3O5/c1-13(22(33)30-17-6-3-14(4-7-17)23(34)35)31-11-20(36-12-24(26,27)28)19(9-21(31)32)18-8-16(25)5-2-15(18)10-29/h2-9,11,13H,12H2,1H3,(H,30,33)(H,34,35) WRRFTLCYPIWABB-UHFFFAOYSA-N 246226 US10183932, Example 131::US9434690, 131::US9822102, Example 131 Coagulation factor XI Homo sapiens 81 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246226&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622953 341104037 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429245 COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38) CJNBXUGWBBVSDD-UHFFFAOYSA-N 246227 US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135 Coagulation factor XI Homo sapiens 130 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86298154 341104038 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429246 COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38) CJNBXUGWBBVSDD-UHFFFAOYSA-N 246227 US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135 Coagulation factor XI Homo sapiens 2.7 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86298154 341104038 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429247 COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36) YNXCWDXRPDZZLO-UHFFFAOYSA-N 246231 US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138 Coagulation factor XI Homo sapiens 1200 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622873 341104039 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429248 CCC1(CC(C(=O)Nc2ccc(cc2)-c2noc(=O)[nH]2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)COC1 246234 US10183932, Example 139::US9434690, 139::US9822102, Example 139 Coagulation factor XI Homo sapiens 2.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246234&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626910 341104040 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429249 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Coagulation factor XI Homo sapiens 190 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429250 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Coagulation factor XI Homo sapiens 0.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429251 COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38) PNSIVGGUCOLACI-UHFFFAOYSA-N 246239 US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147 Coagulation factor XI Homo sapiens 17 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86298155 341104041 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429252 COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38) PNSIVGGUCOLACI-UHFFFAOYSA-N 246239 US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147 Coagulation factor XI Homo sapiens 14 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86298155 341104041 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429253 COc1cn(C(CC2CC(F)(F)C2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H22ClF2N3O5/c1-38-23-14-33(24(34)10-21(23)20-9-18(28)5-2-17(20)13-31)22(8-15-11-27(29,30)12-15)25(35)32-19-6-3-16(4-7-19)26(36)37/h2-7,9-10,14-15,22H,8,11-12H2,1H3,(H,32,35)(H,36,37) IIHVYKJYWMUBJC-UHFFFAOYSA-N 246243 US10183932, Example 149::US9434690, 149::US9822102, Example 149 Coagulation factor XI Homo sapiens 5.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246243&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622900 341104043 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429254 COc1cn(C(CC2(C)CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-29(9-11-39-12-10-29)15-24(27(35)32-21-7-4-18(5-8-21)28(36)37)33-17-25(38-2)23(14-26(33)34)22-13-20(30)6-3-19(22)16-31/h3-8,13-14,17,24H,9-12,15H2,1-2H3,(H,32,35)(H,36,37) PAESNLCGOZMSMT-UHFFFAOYSA-N 246245 US10183932, Example 151::US9434690, 151::US9822102, Example 151 Coagulation factor XI Homo sapiens 14 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246245&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117623020 341104045 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429255 CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26? LARGKTWCHAEXEF-CIGLETDBSA-N 246246 US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154 Coagulation factor XI Homo sapiens 1100 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104046 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429256 CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? LARGKTWCHAEXEF-QDTYANCNSA-N 246249 US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157 Coagulation factor XI Homo sapiens 2.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104047 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429257 CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? LARGKTWCHAEXEF-QDTYANCNSA-N 246249 US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157 Coagulation factor XI Homo sapiens 0.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104047 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429258 COc1cn(C(CC2CCC2)C(=O)Nc2ccc3c(c2)[nH]n(C)c3=O)c(=O)cc1-c1cc(Cl)ccc1C#N 246253 US10183932, Example 159::US9434690, 159::US9822102, Example 159 Coagulation factor XI Homo sapiens 18 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246253&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626911 341104049 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429259 COc1cn(C(C(C)C)C(=O)Nc2ccc(C(O)=O)c(C)c2)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O5/c1-14(2)24(25(32)29-18-7-8-19(26(33)34)15(3)9-18)30-13-22(35-4)21(11-23(30)31)20-10-17(27)6-5-16(20)12-28/h5-11,13-14,24H,1-4H3,(H,29,32)(H,33,34) ZYWDBAHJEMNANX-UHFFFAOYSA-N 246255 US10183932, Example 161::US9434690, 161::US9822102, Example 161 Coagulation factor XI Homo sapiens 2000 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246255&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622965 341104051 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429260 COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H20ClN5O5/c1-35-8-7-21(24(33)28-16-5-6-19-20(10-16)30-25(34)29-19)31-13-22(36-2)18(11-23(31)32)17-9-15(26)4-3-14(17)12-27/h3-6,9-11,13,21H,7-8H2,1-2H3,(H,28,33) LVYGLUYPTDVDIW-UHFFFAOYSA-N 246257 US10183932, Example 163::US9434690, 163::US9822102, Example 163 Coagulation factor XI Homo sapiens 6.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246257&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626912 341104053 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429261 COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246259 US10183932, Example 165::US9434690, 165::US9822102, Example 165 Coagulation factor XI Homo sapiens 11 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246259&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626914 341104055 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429262 COCCC(C(=O)Nc1ccc2[nH]nc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246261 US10183932, Example 167::US9434690, 167::US9822102, Example 167 Coagulation factor XI Homo sapiens 28 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246261&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626916 341104057 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429263 COCCC(C(=O)Nc1cc2[nH]c(cc2cc1OC)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246263 US10183932, Example 169::US9434690, 169::US9822102, Example 169 Coagulation factor XI Homo sapiens 160 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246263&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622918 341104059 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429264 OC(=O)c1ccc(NC(=O)C(CCOC(F)(F)F)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C24H16Cl2F3N3O5/c25-15-4-1-14(11-30)17(9-15)18-10-21(33)32(12-19(18)26)20(7-8-37-24(27,28)29)22(34)31-16-5-2-13(3-6-16)23(35)36/h1-6,9-10,12,20H,7-8H2,(H,31,34)(H,35,36) AHPKGYGFEFPFAF-UHFFFAOYSA-N 246265 US10183932, Example 171::US9434690, 171::US9822102, Example 171 Coagulation factor XI Homo sapiens 5.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246265&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622783 341104061 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429265 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F InChI=1S/C25H23ClF2N2O7/c1-35-10-9-19(23(32)29-16-6-3-14(4-7-16)24(33)34)30-13-21(36-2)18(12-22(30)31)17-11-15(26)5-8-20(17)37-25(27)28/h3-8,11-13,19,25H,9-10H2,1-2H3,(H,29,32)(H,33,34) BRLSWNMQGWOZIZ-UHFFFAOYSA-N 246267 US10183932, Example 173::US9434690, 173::US9822102, Example 173 Coagulation factor XI Homo sapiens 2.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246267&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622938 341104063 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429266 COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F InChI=1S/C25H21ClF2N4O6/c1-36-8-7-19(23(34)29-14-4-5-17-18(10-14)31-25(35)30-17)32-12-21(37-2)16(11-22(32)33)15-9-13(26)3-6-20(15)38-24(27)28/h3-6,9-12,19,24H,7-8H2,1-2H3,(H,29,34) NKCAKTVAUQJXMR-UHFFFAOYSA-N 246269 US10183932, Example 175::US9434690, 175::US9822102, Example 175 Coagulation factor XI Homo sapiens 15 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246269&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626918 341104065 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429267 COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m1/s1 OTYWURKUSAPCDC-LCQOSCCDSA-N 246271 US10183932, Example 177::US9434690, 177::US9822102, Example 177 Coagulation factor XI Homo sapiens 3.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246271&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622940 341104067 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429268 CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-15-6-7-16(24(32)33)19(26)9-15)29-12-21(34-2)18(10-22(29)30)17-8-14(25)5-4-13(17)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33) LRTKHAKNKDKNGN-UHFFFAOYSA-N 246272 US10183932, Example 179::US9434690, 178::US9434690, 179::US9822102, Example 179 Coagulation factor XI Homo sapiens 2.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246272&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622926 341104068 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429269 CCC(C(=O)Nc1ccc(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-19-7-5-13(24(32)33)8-18(19)26)29-12-21(34-2)17(10-22(29)30)16-9-15(25)6-4-14(16)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33) JXWVATDLTXDPIQ-UHFFFAOYSA-N 246274 US10183932, Example 181::US9434690, 180::US9434690, 181::US9822102, Example 181 Coagulation factor XI Homo sapiens 11 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246274&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622633 341104069 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429270 CCC(C(=O)Nc1cc(F)c(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-3-20(23(32)29-19-9-17(26)16(24(33)34)7-18(19)27)30-11-21(35-2)15(8-22(30)31)14-6-13(25)5-4-12(14)10-28/h4-9,11,20H,3H2,1-2H3,(H,29,32)(H,33,34) ZVXCULUAQHRZBD-UHFFFAOYSA-N 246276 US10183932, Example 183::US9434690, 182::US9434690, 183::US9822102, Example 183 Coagulation factor XI Homo sapiens 14 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246276&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622968 341104070 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429271 CCC(C(=O)Nc1cc(F)c(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-3-19(23(32)29-14-7-17(26)22(24(33)34)18(27)8-14)30-11-20(35-2)16(9-21(30)31)15-6-13(25)5-4-12(15)10-28/h4-9,11,19H,3H2,1-2H3,(H,29,32)(H,33,34) UALXRLIAFKMVEE-UHFFFAOYSA-N 246279 US10183932, Example 185::US9434690, 185::US9822102, Example 185 Coagulation factor XI Homo sapiens 5.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246279&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622950 341104072 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429272 CCC(C(=O)Nc1ccc(cc1)-c1nsc(=O)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246280 US10183932, Example 187::US9434690, 186::US9434690, 187::US9822102, Example 187 Coagulation factor XI Homo sapiens 2.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246280&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626919 341104073 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429273 CCC(C(=O)Nc1ccc(cc1)-c1ncco1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H21ClN4O4/c1-3-22(25(33)30-19-8-5-16(6-9-19)26-29-10-11-35-26)31-15-23(34-2)21(13-24(31)32)20-12-18(27)7-4-17(20)14-28/h4-13,15,22H,3H2,1-2H3,(H,30,33) WOVKYOZMJFJOLI-UHFFFAOYSA-N 246283 US10183932, Example 189::US9434690, 189::US9822102, Example 189 Coagulation factor XI Homo sapiens 66 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246283&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622969 341104075 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429274 CCC(C(=O)Nc1ccc(cc1)-c1nnc(C)o1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H22ClN5O4/c1-4-22(25(34)29-19-9-6-16(7-10-19)26-31-30-15(2)36-26)32-14-23(35-3)21(12-24(32)33)20-11-18(27)8-5-17(20)13-28/h5-12,14,22H,4H2,1-3H3,(H,29,34) IWJPZYSOUYLTNJ-UHFFFAOYSA-N 246285 US10183932, Example 191::US9434690, 191::US9822102, Example 191 Coagulation factor XI Homo sapiens 49 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246285&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622798 341104077 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429275 CCC(C(=O)Nc1ccc(cc1)-c1nnc([nH]1)C(F)(F)C(F)(F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246287 US10183932, Example 193::US9434690, 193::US9822102, Example 193 Coagulation factor XI Homo sapiens 2.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246287&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622923 341104079 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429276 CCC(C(=O)Nc1ccc2c(n[nH]c2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246289 US10183932, Example 195::US9434690, 195::US9822102, Example 195 Coagulation factor XI Homo sapiens 150 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246289&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877926 341104081 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429277 CCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246291 US10183932, Example 197::US9434690, 197::US9822102, Example 197 Coagulation factor XI Homo sapiens 17 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246291&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622970 341104083 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429278 COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1 OTYWURKUSAPCDC-YDNXMHBPSA-N 246293 US10183932, Example 199::US9434690, 199::US9822102, Example 199 Coagulation factor XI Homo sapiens 1.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246293&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622782 341104085 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429279 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19Cl2N3O5/c1-34-9-8-21(23(31)28-17-6-3-14(4-7-17)24(32)33)29-13-20(26)19(11-22(29)30)18-10-16(25)5-2-15(18)12-27/h2-7,10-11,13,21H,8-9H2,1H3,(H,28,31)(H,32,33) YWIBKDIZKZBHGC-UHFFFAOYSA-N 246299 US10183932, Example 205::US9434690, 205::US9822102, Example 205 Coagulation factor XI Homo sapiens 4.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246299&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622796 341104087 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429280 CC(C(=O)Nc1ccc(cc1)-c1nc(n[nH]1)C(F)(F)F)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246097 US9434690, 2::US9822102, Example 2 Coagulation factor XI Homo sapiens 260 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246097&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877915 341103946 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429281 CC(C(=O)Nc1ccc(cc1)-c1ncc[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246099 US10183932, Example 4::US9434690, 4::US9822102, Example 4 Coagulation factor XI Homo sapiens 240 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246099&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622607 341103948 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429282 CC(C(=O)Nc1ccc(cc1)-c1c[nH]c(n1)C(F)(F)F)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246101 US10183932, Example 6::US9434690, 6::US9822102, Example 6 Coagulation factor XI Homo sapiens 440 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246101&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622723 341103950 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429283 CC(C(=O)Nc1ccc(cc1)-c1noc(=O)[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246103 US10183932, Example 8::US9434690, 8::US9822102, Example 8 Coagulation factor XI Homo sapiens 110 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246103&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626902 341103952 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429284 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#C InChI=1S/C23H17ClN2O4/c1-3-15-4-7-18(24)13-20(15)17-10-11-26(21(27)12-17)14(2)22(28)25-19-8-5-16(6-9-19)23(29)30/h1,4-14H,2H3,(H,25,28)(H,29,30) QDWJWQDKOZZAQW-UHFFFAOYSA-N 246105 US10183932, Example 10::US9434690, 10::US9822102, Example 10 Coagulation factor XI Homo sapiens 730 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246105&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622825 341103954 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429285 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1ccc(cc1=O)-c1cc(Cl)ccc1Br InChI=1S/C21H16BrClN2O4/c1-12(20(27)24-16-5-2-13(3-6-16)21(28)29)25-9-8-14(10-19(25)26)17-11-15(23)4-7-18(17)22/h2-12H,1H3,(H,24,27)(H,28,29) XJQGLUHBEAPGGL-UHFFFAOYSA-N 246107 US10183932, Example 12::US9434690, 12::US9822102, Example 12 Coagulation factor XI Homo sapiens 500 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246107&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622826 341103956 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429286 CC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15ClFN3O4/c1-12(21(29)26-16-4-5-17(22(30)31)19(24)10-16)27-7-6-13(8-20(27)28)18-9-15(23)3-2-14(18)11-25/h2-10,12H,1H3,(H,26,29)(H,30,31) IMVUPWVKUPCHKR-UHFFFAOYSA-N 246109 US10183932, Example 14::US9434690, 14::US9822102, Example 14 Coagulation factor XI Homo sapiens 330 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246109&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622908 341103958 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429287 CC(C(=O)Nc1ccc(C(O)=O)c(C)c1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C23H18ClN3O4/c1-13-9-18(5-6-19(13)23(30)31)26-22(29)14(2)27-8-7-15(10-21(27)28)20-11-17(24)4-3-16(20)12-25/h3-11,14H,1-2H3,(H,26,29)(H,30,31) YMJHGUUNZKRDJI-UHFFFAOYSA-N 246111 US10183932, Example 16::US9434690, 16::US9822102, Example 16 Coagulation factor XI Homo sapiens 910 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246111&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622735 341103960 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429288 CC(C(=O)Nc1ccc2nc[nH]c2c1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246113 US10183932, Example 18::US9434690, 18::US9822102, Example 18 Coagulation factor XI Homo sapiens 840 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246113&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297342 341103962 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429289 CCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246114 US10183932, Example 21::US9434690, 19::US9434690, 20::US9434690, 21::US9822102, Example 21 Coagulation factor XI Homo sapiens 27000 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246114&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622611 341103963 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429290 CC(C)C(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246117 US10183932, Example 22::US9434690, 22::US9822102, Example 22 Coagulation factor XI Homo sapiens 1700 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246117&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622744 341103964 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429291 OC(=O)c1ccc(NC(=O)C(CC2CC2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C25H20ClF3N2O4/c26-17-5-8-20(25(27,28)29)19(13-17)16-9-10-31(22(32)12-16)21(11-14-1-2-14)23(33)30-18-6-3-15(4-7-18)24(34)35/h3-10,12-14,21H,1-2,11H2,(H,30,33)(H,34,35) JYJMQKSJTFFBCU-UHFFFAOYSA-N 246119 US10183932, Example 24::US9434690, 24::US9822102, Example 24 Coagulation factor XI Homo sapiens 240 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246119&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622833 341103966 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429292 Clc1ccc(C#N)c(c1)-c1ccn(C(Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2nnn[nH]2)c(=O)c1 246121 US10183932, Example 26::US9434690, 26::US9822102, Example 26 Coagulation factor XI Homo sapiens 7.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246121&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626904 341103968 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429293 OC(=O)c1ccc(NC(=O)C(Cc2cccnc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-19-5-8-22(27(29,30)31)21(14-19)18-9-11-34(24(35)13-18)23(12-16-2-1-10-32-15-16)25(36)33-20-6-3-17(4-7-20)26(37)38/h1-11,13-15,23H,12H2,(H,33,36)(H,37,38) LODANOLKNFDNSD-UHFFFAOYSA-N 246123 US10183932, Example 28::US9434690, 28::US9822102, Example 28 Coagulation factor XI Homo sapiens 49 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246123&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622612 341103970 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429294 OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38) VOEMZDCOWSMTBH-UHFFFAOYSA-N 246125 US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32 Coagulation factor XI Homo sapiens 50 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622752 341103972 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429295 OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38) VOEMZDCOWSMTBH-UHFFFAOYSA-N 246125 US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32 Coagulation factor XI Homo sapiens 65 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622752 341103972 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429296 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(F)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15ClFN3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31) BFAOKCDIFBZLTD-UHFFFAOYSA-N 246129 US10183932, Example 34::US9434690, 34::US9822102, Example 34 Coagulation factor XI Homo sapiens 74 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246129&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622987 341103974 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429297 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31) MYLKJUSMRUADNT-UHFFFAOYSA-N 246130 US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37 Coagulation factor XI Homo sapiens 17000 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622690 341103975 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429298 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C(F)F InChI=1S/C22H16Cl2F2N2O4/c1-11(21(30)27-14-5-2-12(3-6-14)22(31)32)28-10-18(24)17(9-19(28)29)16-8-13(23)4-7-15(16)20(25)26/h2-11,20H,1H3,(H,27,30)(H,31,32) BGHKLWUHAXONFV-UHFFFAOYSA-N 246133 US10183932, Example 38::US9434690, 38::US9822102, Example 38 Coagulation factor XI Homo sapiens 230 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246133&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297543 341103976 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429299 CC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H14Cl2FN3O4/c1-11(21(30)27-14-4-5-15(22(31)32)19(25)7-14)28-10-18(24)17(8-20(28)29)16-6-13(23)3-2-12(16)9-26/h2-8,10-11H,1H3,(H,27,30)(H,31,32) IAFAJANRVZTTGY-UHFFFAOYSA-N 246135 US10183932, Example 40::US9434690, 40::US9822102, Example 40 Coagulation factor XI Homo sapiens 35 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246135&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622831 341103978 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429300 CC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H15Cl2N5O3/c1-13(24(34)28-17-6-3-14(4-7-17)21-10-22(32)30-29-21)31-12-20(26)19(9-23(31)33)18-8-16(25)5-2-15(18)11-27/h2-10,12-13H,1H3,(H,28,34) AXABJGPJVKQRBN-UHFFFAOYSA-N 246137 US10183932, Example 42::US9434690, 42::US9822102, Example 42 Coagulation factor XI Homo sapiens 14 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246137&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626905 341103980 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429301 CC(C(=O)Nc1ccc2nc([nH]c2c1)C(F)(F)F)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N 246139 US10183932, Example 44::US9434690, 44::US9822102, Example 44 Coagulation factor XI Homo sapiens 140 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246139&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622619 341103982 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429302 OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34) APZJTXHPPDAWRM-UHFFFAOYSA-N 246140 US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47 Coagulation factor XI Homo sapiens 3300 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622732 341103983 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429303 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(C#N)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C23H15ClN4O4/c1-13(22(30)27-18-6-3-14(4-7-18)23(31)32)28-12-16(11-26)20(9-21(28)29)19-8-17(24)5-2-15(19)10-25/h2-9,12-13H,1H3,(H,27,30)(H,31,32) XUOMLAMFRJTVIB-UHFFFAOYSA-N 246143 US10183932, Example 48::US9434690, 48::US9822102, Example 48 Coagulation factor XI Homo sapiens 42 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246143&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622988 341103984 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429304 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(C#N)c(cc1=O)-c1cc(Cl)ccc1C(F)(F)F InChI=1S/C23H15ClF3N3O4/c1-12(21(32)29-16-5-2-13(3-6-16)22(33)34)30-11-14(10-28)17(9-20(30)31)18-8-15(24)4-7-19(18)23(25,26)27/h2-9,11-12H,1H3,(H,29,32)(H,33,34) CRLAHSLWVRFEPX-UHFFFAOYSA-N 246145 US10183932, Example 50::US9434690, 50::US9822102, Example 50 Coagulation factor XI Homo sapiens 470 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246145&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622992 341103986 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429305 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(C#N)c(cc1=O)-c1cc(Cl)ccc1C1CC1 InChI=1S/C25H20ClN3O4/c1-14(24(31)28-19-7-4-16(5-8-19)25(32)33)29-13-17(12-27)21(11-23(29)30)22-10-18(26)6-9-20(22)15-2-3-15/h4-11,13-15H,2-3H2,1H3,(H,28,31)(H,32,33) FWVQBGXUHYWJAU-UHFFFAOYSA-N 246147 US10183932, Example 52::US9434690, 52::US9822102, Example 52 Coagulation factor XI Homo sapiens 700 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246147&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622622 341103988 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429306 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(c(cc1=O)-c1cc(Cl)ccc1C#N)C(F)(F)F InChI=1S/C23H15ClF3N3O4/c1-12(21(32)29-16-6-3-13(4-7-16)22(33)34)30-11-19(23(25,26)27)18(9-20(30)31)17-8-15(24)5-2-14(17)10-28/h2-9,11-12H,1H3,(H,29,32)(H,33,34) NQZSVOPSABUDTN-UHFFFAOYSA-N 246149 US10183932, Example 54::US9434690, 54::US9822102, Example 54 Coagulation factor XI Homo sapiens 3500 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246149&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622945 341103990 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429307 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31) MPSQYCLTAAEIDL-UHFFFAOYSA-N 246150 US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57 Coagulation factor XI Homo sapiens 3400 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622624 341103991 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429308 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1[N+]([O-])=O InChI=1S/C22H18ClN3O7/c1-12(21(28)24-15-6-3-13(4-7-15)22(29)30)25-11-19(33-2)17(10-20(25)27)16-9-14(23)5-8-18(16)26(31)32/h3-12H,1-2H3,(H,24,28)(H,29,30) PTHBJYOJADPDRP-UHFFFAOYSA-N 246153 US10183932, Example 58::US9434690, 58::US9822102, Example 58 Coagulation factor XI Homo sapiens 3.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246153&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297546 341103992 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429309 COc1cn(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H22ClN3O5/c1-35-23-14-30(24(31)12-21(23)20-11-18(27)7-4-17(20)13-28)22(10-15-2-3-15)25(32)29-19-8-5-16(6-9-19)26(33)34/h4-9,11-12,14-15,22H,2-3,10H2,1H3,(H,29,32)(H,33,34) YEOQEAASRZWJNV-UHFFFAOYSA-N 246154 US10183932, Example 60::US9434690, 59::US9434690, 60::US9822102, Example 60 Coagulation factor XI Homo sapiens 1.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246154&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622901 341103993 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429310 CC(N)Oc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H21ClN4O5/c1-13(23(31)28-18-7-4-15(5-8-18)24(32)33)29-12-21(34-14(2)27)20(10-22(29)30)19-9-17(25)6-3-16(19)11-26/h3-10,12-14H,27H2,1-2H3,(H,28,31)(H,32,33) GAKLGPVSFCHFBY-UHFFFAOYSA-N 246157 US9434690, 62 Coagulation factor XI Homo sapiens 290 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246157&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626906 341103995 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429311 COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34) PDLAMRDOLIUATC-UHFFFAOYSA-N 246158 US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65 Coagulation factor XI Homo sapiens 4000 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622627 341103996 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429312 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32) HUXWVMXMMHUYLB-UHFFFAOYSA-N 246161 US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140 Coagulation factor XI Homo sapiens 4.7 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622754 341103997 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429313 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32) HUXWVMXMMHUYLB-UHFFFAOYSA-N 246161 US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140 Coagulation factor XI Homo sapiens 1.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622754 341103997 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429314 CCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246165 US10183932, Example 70::US9434690, 70::US9822102, Example 70 Coagulation factor XI Homo sapiens 24 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246165&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626908 341103999 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429315 CCC(C(=O)Nc1ccc(cc1)-c1c[nH]c(=O)o1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246167 US10183932, Example 72::US9434690, 72::US9822102, Example 72 Coagulation factor XI Homo sapiens 34 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246167&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622993 341104001 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429316 CCC(C(=O)Nc1ccc2cc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246169 US10183932, Example 74::US9434690, 74::US9822102, Example 74 Coagulation factor XI Homo sapiens 17 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246169&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622760 341104003 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429317 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33) XAYFQGTYMRMPAS-UHFFFAOYSA-N 246171 US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78 Coagulation factor XI Homo sapiens 1.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297748 341104005 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429318 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33) XAYFQGTYMRMPAS-UHFFFAOYSA-N 246171 US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78 Coagulation factor XI Homo sapiens 1.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297748 341104005 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429319 CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1 DYNSAJCVHKUDFF-UEDXYCIISA-N 246174 US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81 Coagulation factor XI Homo sapiens 4000 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877945 341104006 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429320 CO[C@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m1/s1 DYNSAJCVHKUDFF-JGHKVMFLSA-N 246177 US10183932, Example 83::US9434690, 82::US9434690, 83::US9822102, Example 83 Coagulation factor XI Homo sapiens 18 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246177&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877889 341104007 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429321 COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1 AETBCOOBUYAHJM-PPUHSXQSSA-N 246179 US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86 Coagulation factor XI Homo sapiens 4.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622620 341104008 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429322 COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1 AETBCOOBUYAHJM-PPUHSXQSSA-N 246179 US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86 Coagulation factor XI Homo sapiens 2.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622620 341104008 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429323 COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1 AETBCOOBUYAHJM-AJZOCDQUSA-N 246182 US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89 Coagulation factor XI Homo sapiens 1.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 118877947 341104009 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429324 COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35) UPJPTNTVAMVKSD-UHFFFAOYSA-N 246185 US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93 Coagulation factor XI Homo sapiens 8.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297749 341104010 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429325 COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35) UPJPTNTVAMVKSD-UHFFFAOYSA-N 246185 US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93 Coagulation factor XI Homo sapiens 3.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297749 341104010 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429326 COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36) BMRPDPXXIHCBMO-UHFFFAOYSA-N 246189 US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96 Coagulation factor XI Homo sapiens 5.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297750 341104011 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429327 COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36) BMRPDPXXIHCBMO-UHFFFAOYSA-N 246189 US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96 Coagulation factor XI Homo sapiens 2.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297750 341104011 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429328 COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36) SNVIVXDTJLCEGY-UHFFFAOYSA-N 246192 US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100 Coagulation factor XI Homo sapiens 890 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622761 341104012 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429329 COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36) SNVIVXDTJLCEGY-UHFFFAOYSA-N 246192 US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100 Coagulation factor XI Homo sapiens 1.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622761 341104012 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429330 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Coagulation factor XI Homo sapiens 660 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429331 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Coagulation factor XI Homo sapiens 7.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429332 COc1cn(C(CC2COCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O7/c1-36-24-14-31(25(32)12-22(24)21-10-18(28)5-2-17(21)13-29)23(11-20-15-37-8-9-38-20)26(33)30-19-6-3-16(4-7-19)27(34)35/h2-7,10,12,14,20,23H,8-9,11,15H2,1H3,(H,30,33)(H,34,35) BHLQGSGEFNRQIY-UHFFFAOYSA-N 246201 US10183932, Example 106::US9434690, 106::US9822102, Example 106 Coagulation factor XI Homo sapiens 2.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246201&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622773 341104014 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429333 COc1cn(C(CC(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-35-20-12-30(22(31)9-18(20)17-8-15(25)5-2-14(17)11-28)19(10-21(26)27)23(32)29-16-6-3-13(4-7-16)24(33)34/h2-9,12,19,21H,10H2,1H3,(H,29,32)(H,33,34) MGICMZBKNIZMHA-UHFFFAOYSA-N 246203 US10183932, Example 108::US9434690, 108::US9822102, Example 108 Coagulation factor XI Homo sapiens 6.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246203&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622933 341104016 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429334 COc1cn(C(CC(C)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H21ClFN3O5/c1-14(27)9-21(24(32)29-18-7-4-15(5-8-18)25(33)34)30-13-22(35-2)20(11-23(30)31)19-10-17(26)6-3-16(19)12-28/h3-8,10-11,13-14,21H,9H2,1-2H3,(H,29,32)(H,33,34) ZQIKHBBWQGREQS-UHFFFAOYSA-N 246205 US10183932, Example 110::US9434690, 110::US9822102, Example 110 Coagulation factor XI Homo sapiens 9.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246205&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297752 341104018 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429335 COc1cn(C(CC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H26ClN3O5/c1-27(2,3)13-22(25(33)30-19-9-6-16(7-10-19)26(34)35)31-15-23(36-4)21(12-24(31)32)20-11-18(28)8-5-17(20)14-29/h5-12,15,22H,13H2,1-4H3,(H,30,33)(H,34,35) JQVBPYPYIBVMCC-UHFFFAOYSA-N 246207 US10183932, Example 112::US9434690, 112::US9822102, Example 112 Coagulation factor XI Homo sapiens 32 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246207&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297948 341104020 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429336 COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36) PPOMRFJZWPHFPA-UHFFFAOYSA-N 246208 US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115 Coagulation factor XI Homo sapiens 600 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297949 341104021 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429337 COc1cn(C(CC2(C)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O5/c1-27(9-10-27)13-22(25(33)30-19-7-4-16(5-8-19)26(34)35)31-15-23(36-2)21(12-24(31)32)20-11-18(28)6-3-17(20)14-29/h3-8,11-12,15,22H,9-10,13H2,1-2H3,(H,30,33)(H,34,35) DCFGHORVDDAJPY-UHFFFAOYSA-N 246211 US10183932, Example 116::US9434690, 116::US9822102, Example 116 Coagulation factor XI Homo sapiens 2.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246211&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622788 341104022 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429338 CCOC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O6/c1-3-34-23(22(30)27-17-8-5-14(6-9-17)24(31)32)28-13-20(33-2)19(11-21(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,23H,3H2,1-2H3,(H,27,30)(H,31,32) MUNUHSGUPNMRDO-UHFFFAOYSA-N 246213 US10183932, Example 118::US9434690, 118::US9822102, Example 118 Coagulation factor XI Homo sapiens 53 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246213&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117623009 341104024 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429339 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)(F)F InChI=1S/C23H18ClF3N2O6/c1-12(21(31)28-15-6-3-13(4-7-15)22(32)33)29-11-19(34-2)17(10-20(29)30)16-9-14(24)5-8-18(16)35-23(25,26)27/h3-12H,1-2H3,(H,28,31)(H,32,33) GFKPUVWPTOOUNN-UHFFFAOYSA-N 246215 US10183932, Example 120::US9434690, 120::US9822102, Example 120 Coagulation factor XI Homo sapiens 46 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246215&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622891 341104026 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429340 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C InChI=1S/C23H21ClN2O5/c1-13-4-7-16(24)10-18(13)19-11-21(27)26(12-20(19)31-3)14(2)22(28)25-17-8-5-15(6-9-17)23(29)30/h4-12,14H,1-3H3,(H,25,28)(H,29,30) CVTZPKKDPIRSKS-UHFFFAOYSA-N 246217 US10183932, Example 122::US9434690, 122::US9822102, Example 122 Coagulation factor XI Homo sapiens 52 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246217&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622769 341104028 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429341 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1CC1 InChI=1S/C25H23ClN2O5/c1-14(24(30)27-18-8-5-16(6-9-18)25(31)32)28-13-22(33-2)21(12-23(28)29)20-11-17(26)7-10-19(20)15-3-4-15/h5-15H,3-4H2,1-2H3,(H,27,30)(H,31,32) KCVUSOULLFFMAD-UHFFFAOYSA-N 246219 US10183932, Example 124::US9434690, 124::US9822102, Example 124 Coagulation factor XI Homo sapiens 170 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246219&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117623015 341104030 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429342 COc1cn(C(CCO)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O6/c1-34-21-13-28(22(30)11-19(21)18-10-16(25)5-2-15(18)12-26)20(8-9-29)23(31)27-17-6-3-14(4-7-17)24(32)33/h2-7,10-11,13,20,29H,8-9H2,1H3,(H,27,31)(H,32,33) BKTRHZIMQRNWEQ-UHFFFAOYSA-N 246221 US10183932, Example 126::US9434690, 126::US9822102, Example 126 Coagulation factor XI Homo sapiens 7.1 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246221&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622878 341104032 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429343 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F InChI=1S/C24H21ClF2N2O6/c1-3-18(22(31)28-15-7-4-13(5-8-15)23(32)33)29-12-20(34-2)17(11-21(29)30)16-10-14(25)6-9-19(16)35-24(26)27/h4-12,18,24H,3H2,1-2H3,(H,28,31)(H,32,33) BGDFMSJIOCVRBT-UHFFFAOYSA-N 246223 US10183932, Example 128::US9434690, 128::US9822102, Example 128 Coagulation factor XI Homo sapiens 11 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246223&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622790 341104034 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429344 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC(F)F)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C23H16ClF2N3O5/c1-12(21(31)28-16-6-3-13(4-7-16)22(32)33)29-11-19(34-23(25)26)18(9-20(29)30)17-8-15(24)5-2-14(17)10-27/h2-9,11-12,23H,1H3,(H,28,31)(H,32,33) XEVLNKRJTMYBIC-UHFFFAOYSA-N 246225 US10183932, Example 130::US9434690, 130::US9822102, Example 130 Coagulation factor XI Homo sapiens 50 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246225&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622897 341104036 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429345 COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38) CJNBXUGWBBVSDD-UHFFFAOYSA-N 246227 US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135 Coagulation factor XI Homo sapiens 2.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86298154 341104038 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429346 COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38) CJNBXUGWBBVSDD-UHFFFAOYSA-N 246227 US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135 Coagulation factor XI Homo sapiens 0.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86298154 341104038 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429347 COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36) YNXCWDXRPDZZLO-UHFFFAOYSA-N 246231 US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138 Coagulation factor XI Homo sapiens 1.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622873 341104039 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429348 COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36) YNXCWDXRPDZZLO-UHFFFAOYSA-N 246231 US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138 Coagulation factor XI Homo sapiens 1.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622873 341104039 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429349 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32) HUXWVMXMMHUYLB-UHFFFAOYSA-N 246161 US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140 Coagulation factor XI Homo sapiens 3.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622754 341103997 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429350 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Coagulation factor XI Homo sapiens 3.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429351 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Coagulation factor XI Homo sapiens 98 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429352 COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38) PNSIVGGUCOLACI-UHFFFAOYSA-N 246239 US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147 Coagulation factor XI Homo sapiens 130 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 86298155 341104041 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429353 COc1cn(C(CC2(CCC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H23ClF3N3O5/c1-40-23-15-35(24(36)12-21(23)20-11-18(29)6-3-17(20)14-33)22(13-27(9-2-10-27)28(30,31)32)25(37)34-19-7-4-16(5-8-19)26(38)39/h3-8,11-12,15,22H,2,9-10,13H2,1H3,(H,34,37)(H,38,39) NNYYRFPFZSEPNY-UHFFFAOYSA-N 246242 US10183932, Example 148::US9434690, 148::US9822102, Example 148 Coagulation factor XI Homo sapiens 59 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246242&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117623022 341104042 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429354 COc1cn(C(CC2(C)COC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-27(14-37-15-27)11-22(25(33)30-19-7-4-16(5-8-19)26(34)35)31-13-23(36-2)21(10-24(31)32)20-9-18(28)6-3-17(20)12-29/h3-10,13,22H,11,14-15H2,1-2H3,(H,30,33)(H,34,35) UCSCLOQQIVMMIJ-UHFFFAOYSA-N 246244 US10183932, Example 150::US9434690, 150::US9822102, Example 150 Coagulation factor XI Homo sapiens 4.7 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246244&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622630 341104044 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429355 CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26? LARGKTWCHAEXEF-CIGLETDBSA-N 246246 US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154 Coagulation factor XI Homo sapiens 5.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104046 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429356 CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26? LARGKTWCHAEXEF-CIGLETDBSA-N 246246 US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154 Coagulation factor XI Homo sapiens 2.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104046 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429357 CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? LARGKTWCHAEXEF-QDTYANCNSA-N 246249 US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157 Coagulation factor XI Homo sapiens 600 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104047 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429358 COc1cn(C(CC2CCC2)C(=O)Nc2ccc(cc2)-c2c[nH]c(=O)o2)c(=O)cc1-c1cc(Cl)ccc1C#N 246252 US10183932, Example 158::US9434690, 158::US9822102, Example 158 Coagulation factor XI Homo sapiens 22 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246252&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622778 341104048 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429359 COc1cn(C(C(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H22ClN3O5/c1-14(2)23(24(31)28-18-8-5-15(6-9-18)25(32)33)29-13-21(34-3)20(11-22(29)30)19-10-17(26)7-4-16(19)12-27/h4-11,13-14,23H,1-3H3,(H,28,31)(H,32,33) SGNRWMZAJNVPLX-UHFFFAOYSA-N 246254 US10183932, Example 160::US9434690, 160::US9822102, Example 160 Coagulation factor XI Homo sapiens 120 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246254&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622781 341104050 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429360 COc1cn(C(C(C)C)C(=O)Nc2ccc3nc([nH]c3c2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N 246256 US10183932, Example 162::US9434690, 162::US9822102, Example 162 Coagulation factor XI Homo sapiens 1100 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246256&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622907 341104052 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429361 COCCC(C(=O)Nc1ccc2c(c1)[nH][nH]c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H20ClN5O5/c1-35-8-7-21(25(34)28-16-5-6-17-20(10-16)29-30-24(17)33)31-13-22(36-2)19(11-23(31)32)18-9-15(26)4-3-14(18)12-27/h3-6,9-11,13,21H,7-8H2,1-2H3,(H,28,34) LSOXVFXTZIMGBB-UHFFFAOYSA-N 246258 US10183932, Example 164::US9434690, 164::US9822102, Example 164 Coagulation factor XI Homo sapiens 2.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246258&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626913 341104054 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429362 COCCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246260 US10183932, Example 166::US9434690, 166::US9822102, Example 166 Coagulation factor XI Homo sapiens 6.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246260&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626915 341104056 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429363 COCCC(C(=O)Nc1ccc2cc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246262 US10183932, Example 168::US9434690, 168::US9822102, Example 168 Coagulation factor XI Homo sapiens 3.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246262&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622955 341104058 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429364 CC(C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H21Cl2N3O4/c1-14(2)9-22(24(32)29-18-7-4-15(5-8-18)25(33)34)30-13-21(27)20(11-23(30)31)19-10-17(26)6-3-16(19)12-28/h3-8,10-11,13-14,22H,9H2,1-2H3,(H,29,32)(H,33,34) AMIQZUOXODCISO-UHFFFAOYSA-N 246264 US10183932, Example 170::US9434690, 170::US9822102, Example 170 Coagulation factor XI Homo sapiens 49 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246264&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622957 341104060 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429365 COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C26H25ClF2N2O6/c1-14(2)10-20(24(33)30-17-7-4-15(5-8-17)25(34)35)31-13-22(36-3)19(12-23(31)32)18-11-16(27)6-9-21(18)37-26(28)29/h4-9,11-14,20,26H,10H2,1-3H3,(H,30,33)(H,34,35) PONZAFSAZRCPMW-UHFFFAOYSA-N 246266 US10183932, Example 172::US9434690, 172::US9822102, Example 172 Coagulation factor XI Homo sapiens 21 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246266&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117623021 341104062 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429366 COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F 246268 US10183932, Example 174::US9434690, 174::US9822102, Example 174 Coagulation factor XI Homo sapiens 19 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246268&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626917 341104064 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429367 COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C25H20ClF5N2O7/c1-38-20-12-33(21(34)11-17(20)16-10-14(26)4-7-19(16)40-24(27)28)18(8-9-39-25(29,30)31)22(35)32-15-5-2-13(3-6-15)23(36)37/h2-7,10-12,18,24H,8-9H2,1H3,(H,32,35)(H,36,37) MQEMRRKVUTYPQR-UHFFFAOYSA-N 246270 US10183932, Example 176::US9434690, 176::US9822102, Example 176 Coagulation factor XI Homo sapiens 4.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246270&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622904 341104066 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429368 CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-15-6-7-16(24(32)33)19(26)9-15)29-12-21(34-2)18(10-22(29)30)17-8-14(25)5-4-13(17)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33) LRTKHAKNKDKNGN-UHFFFAOYSA-N 246272 US10183932, Example 179::US9434690, 178::US9434690, 179::US9822102, Example 179 Coagulation factor XI Homo sapiens 3.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246272&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622926 341104068 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429369 CCC(C(=O)Nc1ccc(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-19-7-5-13(24(32)33)8-18(19)26)29-12-21(34-2)17(10-22(29)30)16-9-15(25)6-4-14(16)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33) JXWVATDLTXDPIQ-UHFFFAOYSA-N 246274 US10183932, Example 181::US9434690, 180::US9434690, 181::US9822102, Example 181 Coagulation factor XI Homo sapiens 13 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246274&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622633 341104069 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429370 CCC(C(=O)Nc1cc(F)c(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-3-20(23(32)29-19-9-17(26)16(24(33)34)7-18(19)27)30-11-21(35-2)15(8-22(30)31)14-6-13(25)5-4-12(14)10-28/h4-9,11,20H,3H2,1-2H3,(H,29,32)(H,33,34) ZVXCULUAQHRZBD-UHFFFAOYSA-N 246276 US10183932, Example 183::US9434690, 182::US9434690, 183::US9822102, Example 183 Coagulation factor XI Homo sapiens 31 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246276&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622968 341104070 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429371 CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-3-18(23(32)29-17-7-6-14(24(33)34)21(26)22(17)27)30-11-19(35-2)16(9-20(30)31)15-8-13(25)5-4-12(15)10-28/h4-9,11,18H,3H2,1-2H3,(H,29,32)(H,33,34) BSTJIMFCDNVZGR-UHFFFAOYSA-N 246278 US10183932, Example 184::US9434690, 184::US9822102, Example 184 Coagulation factor XI Homo sapiens 10 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246278&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622631 341104071 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429372 CCC(C(=O)Nc1ccc(cc1)-c1nsc(=O)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246280 US10183932, Example 187::US9434690, 186::US9434690, 187::US9822102, Example 187 Coagulation factor XI Homo sapiens 5.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246280&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626919 341104073 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429373 CCC(C(=O)Nc1ccc(cc1)-c1noc(=S)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246282 US10183932, Example 188::US9434690, 188::US9822102, Example 188 Coagulation factor XI Homo sapiens 4.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246282&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626920 341104074 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429374 CCC(C(=O)Nc1ccc(cc1)-c1ncon1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H20ClN5O4/c1-3-21(25(33)29-18-8-5-15(6-9-18)24-28-14-35-30-24)31-13-22(34-2)20(11-23(31)32)19-10-17(26)7-4-16(19)12-27/h4-11,13-14,21H,3H2,1-2H3,(H,29,33) JIVAXRBOSDSXCF-UHFFFAOYSA-N 246284 US10183932, Example 190::US9434690, 190::US9822102, Example 190 Coagulation factor XI Homo sapiens 80 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246284&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117623031 341104076 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429375 CCC(C(=O)Nc1ccc(cc1)-c1nnc([nH]1)C(F)(F)C(F)(F)C(=O)OC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246286 US10183932, Example 192::US9434690, 192::US9822102, Example 192 Coagulation factor XI Homo sapiens 3.0 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246286&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622636 341104078 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429376 CCC(C(=O)Nc1cc(F)c2c(c1)[nH][nH]c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H17ClFN5O4/c1-3-19(23(33)28-14-7-17(26)22-18(8-14)29-30-24(22)34)31-11-20(35-2)16(9-21(31)32)15-6-13(25)5-4-12(15)10-27/h4-9,11,19H,3H2,1-2H3,(H,28,33) GKSXPUJAHJCWDQ-UHFFFAOYSA-N 246288 US10183932, Example 194::US9434690, 194::US9822102, Example 194 Coagulation factor XI Homo sapiens 6.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246288&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 129626921 341104080 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429377 CCC(C(=O)Nc1ccc2[nH]nc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246290 US10183932, Example 196::US9434690, 196::US9822102, Example 196 Coagulation factor XI Homo sapiens 110 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246290&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622966 341104082 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429378 COc1cn(C(CC2CCS(=O)(=O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O7S/c1-39-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-40(37,38)11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36) PDHWFIGBHMGYOO-UHFFFAOYSA-N 246292 US10183932, Example 198::US9434690, 198::US9822102, Example 198 Coagulation factor XI Homo sapiens 12 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246292&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622799 341104084 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429379 OC(=O)c1ccc(NC(=O)C(C[C@@H]2CCCCO2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C27H23Cl2N3O5/c28-18-7-4-17(14-30)21(11-18)22-13-25(33)32(15-23(22)29)24(12-20-3-1-2-10-37-20)26(34)31-19-8-5-16(6-9-19)27(35)36/h4-9,11,13,15,20,24H,1-3,10,12H2,(H,31,34)(H,35,36)/t20-,24?/m0/s1 KBFYCDAOFYYRQQ-QHELBMECSA-N 246296 US10183932, Example 202::US9434690, 202::US9822102, Example 202 Coagulation factor XI Homo sapiens 2.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803375 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246296&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search 117622964 341104086 1 MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV 1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT Coagulation factor XI FA11_HUMAN P03951 D3DP64 Q4W5C2 Q9Y495 429380 CC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246096 US10183932, Example 1::US9434690, 1::US9822102, Example 1 Plasma kallikrein Human 600 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622715 341103945 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429381 CC(C(=O)Nc1ccc(cc1)-c1ncc[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246099 US10183932, Example 4::US9434690, 4::US9822102, Example 4 Plasma kallikrein Human 590 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622607 341103948 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429382 CC(C(=O)Nc1ccc(cc1)-c1c[nH]c(n1)C(F)(F)F)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246101 US10183932, Example 6::US9434690, 6::US9822102, Example 6 Plasma kallikrein Human 640 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622723 341103950 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429383 CC(C(=O)Nc1ccc(cc1)-c1noc(=O)[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246103 US10183932, Example 8::US9434690, 8::US9822102, Example 8 Plasma kallikrein Human 490 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626902 341103952 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429384 CC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246112 US10183932, Example 17::US9434690, 17::US9822102, Example 17 Plasma kallikrein Human 630 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626903 341103961 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429385 CCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246114 US10183932, Example 21::US9434690, 19::US9434690, 20::US9434690, 21::US9822102, Example 21 Plasma kallikrein Human 120 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622611 341103963 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429386 CCCCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246118 US10183932, Example 23::US9434690, 23::US9822102, Example 23 Plasma kallikrein Human 520 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622898 341103965 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429387 OC(=O)c1ccc(NC(=O)C(Cc2ccccn2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-18-6-9-22(27(29,30)31)21(14-18)17-10-12-34(24(35)13-17)23(15-20-3-1-2-11-32-20)25(36)33-19-7-4-16(5-8-19)26(37)38/h1-14,23H,15H2,(H,33,36)(H,37,38) CKFCLGOBAUZLCA-UHFFFAOYSA-N 246122 US10183932, Example 27::US9434690, 27::US9822102, Example 27 Plasma kallikrein Human 780 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622905 341103969 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429388 OC(=O)c1ccc(NC(=O)C(Cc2cccnc2)n2ccc(cc2=O)-c2cc(Cl)ccc2Br)cc1 InChI=1S/C26H19BrClN3O4/c27-22-8-5-19(28)14-21(22)18-9-11-31(24(32)13-18)23(12-16-2-1-10-29-15-16)25(33)30-20-6-3-17(4-7-20)26(34)35/h1-11,13-15,23H,12H2,(H,30,33)(H,34,35) FJLLPUNDAQQFCD-UHFFFAOYSA-N 246124 US10183932, Example 29::US9434690, 29::US9822102, Example 29 Plasma kallikrein Human 350 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622939 341103971 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429389 OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38) VOEMZDCOWSMTBH-UHFFFAOYSA-N 246125 US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32 Plasma kallikrein Human 800 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622752 341103972 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429390 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(F)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15ClFN3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31) BFAOKCDIFBZLTD-UHFFFAOYSA-N 246129 US10183932, Example 34::US9434690, 34::US9822102, Example 34 Plasma kallikrein Human 310 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622987 341103974 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429391 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31) MYLKJUSMRUADNT-UHFFFAOYSA-N 246130 US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37 Plasma kallikrein Human 275 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622690 341103975 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429392 CC(C(=O)Nc1ccc(cc1)-c1nc(n[nH]1)C(F)(F)F)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N 246136 US10183932, Example 41::US9434690, 41::US9822102, Example 41 Plasma kallikrein Human 1600 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622989 341103979 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429393 CC(C(=O)Nc1ccc(cc1)-c1cnc[nH]1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N 246138 US10183932, Example 43::US9434690, 43::US9822102, Example 43 Plasma kallikrein Human 230 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622610 341103981 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429394 OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34) APZJTXHPPDAWRM-UHFFFAOYSA-N 246140 US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47 Plasma kallikrein Human 200 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622732 341103983 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429395 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31) MPSQYCLTAAEIDL-UHFFFAOYSA-N 246150 US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57 Plasma kallikrein Human 31 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622624 341103991 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429396 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1[N+]([O-])=O InChI=1S/C22H18ClN3O7/c1-12(21(28)24-15-6-3-13(4-7-15)22(29)30)25-11-19(33-2)17(10-20(25)27)16-9-14(23)5-8-18(16)26(31)32/h3-12H,1-2H3,(H,24,28)(H,29,30) PTHBJYOJADPDRP-UHFFFAOYSA-N 246153 US10183932, Example 58::US9434690, 58::US9822102, Example 58 Plasma kallikrein Human 46 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246153&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297546 341103992 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429397 COc1cn(C(CC#C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H18ClN3O5/c1-3-4-21(24(31)28-18-9-6-15(7-10-18)25(32)33)29-14-22(34-2)20(12-23(29)30)19-11-17(26)8-5-16(19)13-27/h1,5-12,14,21H,4H2,2H3,(H,28,31)(H,32,33) BVJKTUAUDCSIJC-UHFFFAOYSA-N 246156 US10183932, Example 61::US9434690, 61::US9822102, Example 61 Plasma kallikrein Human 29 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246156&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622828 341103994 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429398 COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34) PDLAMRDOLIUATC-UHFFFAOYSA-N 246158 US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65 Plasma kallikrein Human 25 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622627 341103996 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429399 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32) HUXWVMXMMHUYLB-UHFFFAOYSA-N 246161 US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140 Plasma kallikrein Human 14.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622754 341103997 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429400 CCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246165 US10183932, Example 70::US9434690, 70::US9822102, Example 70 Plasma kallikrein Human 16 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246165&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626908 341103999 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429401 CCC(C(=O)Nc1ccc(cc1)-c1c[nH]c(=O)o1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246167 US10183932, Example 72::US9434690, 72::US9822102, Example 72 Plasma kallikrein Human 29 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246167&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622993 341104001 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429402 CCC(C(=O)Nc1ccc2cc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246169 US10183932, Example 74::US9434690, 74::US9822102, Example 74 Plasma kallikrein Human 10 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622760 341104003 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429403 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33) XAYFQGTYMRMPAS-UHFFFAOYSA-N 246171 US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78 Plasma kallikrein Human 12 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297748 341104005 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429404 CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1 DYNSAJCVHKUDFF-UEDXYCIISA-N 246174 US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81 Plasma kallikrein Human 15 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877945 341104006 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429405 CO[C@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m1/s1 DYNSAJCVHKUDFF-JGHKVMFLSA-N 246177 US10183932, Example 83::US9434690, 82::US9434690, 83::US9822102, Example 83 Plasma kallikrein Human 45 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877889 341104007 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429406 COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1 AETBCOOBUYAHJM-PPUHSXQSSA-N 246179 US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86 Plasma kallikrein Human 40 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622620 341104008 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429407 COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1 AETBCOOBUYAHJM-AJZOCDQUSA-N 246182 US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89 Plasma kallikrein Human 14 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877947 341104009 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429408 COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1 AETBCOOBUYAHJM-AJZOCDQUSA-N 246182 US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89 Plasma kallikrein Human 850 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877947 341104009 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429409 COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35) UPJPTNTVAMVKSD-UHFFFAOYSA-N 246185 US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93 Plasma kallikrein Human 35 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297749 341104010 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429410 COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36) BMRPDPXXIHCBMO-UHFFFAOYSA-N 246189 US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96 Plasma kallikrein Human 48 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297750 341104011 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429411 COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36) SNVIVXDTJLCEGY-UHFFFAOYSA-N 246192 US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100 Plasma kallikrein Human 26 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622761 341104012 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429412 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Plasma kallikrein Human 19 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429413 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Plasma kallikrein Human 67 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429414 COc1cn(C(CC2COCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O7/c1-36-24-14-31(25(32)12-22(24)21-10-18(28)5-2-17(21)13-29)23(11-20-15-37-8-9-38-20)26(33)30-19-6-3-16(4-7-19)27(34)35/h2-7,10,12,14,20,23H,8-9,11,15H2,1H3,(H,30,33)(H,34,35) BHLQGSGEFNRQIY-UHFFFAOYSA-N 246201 US10183932, Example 106::US9434690, 106::US9822102, Example 106 Plasma kallikrein Human 21 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246201&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622773 341104014 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429415 COc1cn(C(CC(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-35-20-12-30(22(31)9-18(20)17-8-15(25)5-2-14(17)11-28)19(10-21(26)27)23(32)29-16-6-3-13(4-7-16)24(33)34/h2-9,12,19,21H,10H2,1H3,(H,29,32)(H,33,34) MGICMZBKNIZMHA-UHFFFAOYSA-N 246203 US10183932, Example 108::US9434690, 108::US9822102, Example 108 Plasma kallikrein Human 59 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622933 341104016 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429416 COc1cn(C(CC(C)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H21ClFN3O5/c1-14(27)9-21(24(32)29-18-7-4-15(5-8-18)25(33)34)30-13-22(35-2)20(11-23(30)31)19-10-17(26)6-3-16(19)12-28/h3-8,10-11,13-14,21H,9H2,1-2H3,(H,29,32)(H,33,34) ZQIKHBBWQGREQS-UHFFFAOYSA-N 246205 US10183932, Example 110::US9434690, 110::US9822102, Example 110 Plasma kallikrein Human 78 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246205&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297752 341104018 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429417 COc1cn(C(CC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H26ClN3O5/c1-27(2,3)13-22(25(33)30-19-9-6-16(7-10-19)26(34)35)31-15-23(36-4)21(12-24(31)32)20-11-18(28)8-5-17(20)14-29/h5-12,15,22H,13H2,1-4H3,(H,30,33)(H,34,35) JQVBPYPYIBVMCC-UHFFFAOYSA-N 246207 US10183932, Example 112::US9434690, 112::US9822102, Example 112 Plasma kallikrein Human 200 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246207&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297948 341104020 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429418 COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36) PPOMRFJZWPHFPA-UHFFFAOYSA-N 246208 US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115 Plasma kallikrein Human 16 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297949 341104021 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429419 COc1cn(C(CC2CCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O5/c1-36-24-15-31(25(32)13-22(24)21-12-19(28)8-5-18(21)14-29)23(11-16-3-2-4-16)26(33)30-20-9-6-17(7-10-20)27(34)35/h5-10,12-13,15-16,23H,2-4,11H2,1H3,(H,30,33)(H,34,35) BXIDJSNINHKLLQ-UHFFFAOYSA-N 246212 US10183932, Example 117::US9434690, 117::US9822102, Example 117 Plasma kallikrein Human 12 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246212&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297950 341104023 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429420 COc1cn(CC(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C22H16ClN3O5/c1-31-19-11-26(12-20(27)25-16-6-3-13(4-7-16)22(29)30)21(28)9-18(19)17-8-15(23)5-2-14(17)10-24/h2-9,11H,12H2,1H3,(H,25,27)(H,29,30) SAHCVGAZLPRNEE-UHFFFAOYSA-N 246214 US10183932, Example 119::US9434690, 119::US9822102, Example 119 Plasma kallikrein Human 200 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246214&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622872 341104025 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429421 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C InChI=1S/C23H21ClN2O5/c1-13-4-7-16(24)10-18(13)19-11-21(27)26(12-20(19)31-3)14(2)22(28)25-17-8-5-15(6-9-17)23(29)30/h4-12,14H,1-3H3,(H,25,28)(H,29,30) CVTZPKKDPIRSKS-UHFFFAOYSA-N 246217 US10183932, Example 122::US9434690, 122::US9822102, Example 122 Plasma kallikrein Human 700 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246217&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622769 341104028 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429422 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Plasma kallikrein Human 23 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429423 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C23H19ClF2N2O6/c1-12(21(30)27-15-6-3-13(4-7-15)22(31)32)28-11-19(33-2)17(10-20(28)29)16-9-14(24)5-8-18(16)34-23(25)26/h3-12,23H,1-2H3,(H,27,30)(H,31,32) YRKPZRMKWAQTNS-UHFFFAOYSA-N 246222 US10183932, Example 127::US9434690, 127::US9822102, Example 127 Plasma kallikrein Human 160 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246222&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622893 341104033 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429424 CCOc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-33-21-13-28(14(2)23(30)27-18-8-5-15(6-9-18)24(31)32)22(29)11-20(21)19-10-17(25)7-4-16(19)12-26/h4-11,13-14H,3H2,1-2H3,(H,27,30)(H,31,32) MHLRUCJOXJQBOK-UHFFFAOYSA-N 246224 US10183932, Example 129::US9434690, 129::US9822102, Example 129 Plasma kallikrein Human 390 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246224&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622947 341104035 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429425 COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38) CJNBXUGWBBVSDD-UHFFFAOYSA-N 246227 US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135 Plasma kallikrein Human 18 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86298154 341104038 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429426 COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38) CJNBXUGWBBVSDD-UHFFFAOYSA-N 246227 US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135 Plasma kallikrein Human 19 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86298154 341104038 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429427 COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36) YNXCWDXRPDZZLO-UHFFFAOYSA-N 246231 US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138 Plasma kallikrein Human 6.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622873 341104039 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429428 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32) HUXWVMXMMHUYLB-UHFFFAOYSA-N 246161 US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140 Plasma kallikrein Human 32 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622754 341103997 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429429 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Plasma kallikrein Human 18 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429430 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Plasma kallikrein Human 1000 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429431 COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38) PNSIVGGUCOLACI-UHFFFAOYSA-N 246239 US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147 Plasma kallikrein Human 1500 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86298155 341104041 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429432 COc1cn(C(CC2(CCC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H23ClF3N3O5/c1-40-23-15-35(24(36)12-21(23)20-11-18(29)6-3-17(20)14-33)22(13-27(9-2-10-27)28(30,31)32)25(37)34-19-7-4-16(5-8-19)26(38)39/h3-8,11-12,15,22H,2,9-10,13H2,1H3,(H,34,37)(H,38,39) NNYYRFPFZSEPNY-UHFFFAOYSA-N 246242 US10183932, Example 148::US9434690, 148::US9822102, Example 148 Plasma kallikrein Human 430 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117623022 341104042 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429433 COc1cn(C(CC2(C)COC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-27(14-37-15-27)11-22(25(33)30-19-7-4-16(5-8-19)26(34)35)31-13-23(36-2)21(10-24(31)32)20-9-18(28)6-3-17(20)12-29/h3-10,13,22H,11,14-15H2,1-2H3,(H,30,33)(H,34,35) UCSCLOQQIVMMIJ-UHFFFAOYSA-N 246244 US10183932, Example 150::US9434690, 150::US9822102, Example 150 Plasma kallikrein Human 18 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246244&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622630 341104044 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429434 CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26? LARGKTWCHAEXEF-CIGLETDBSA-N 246246 US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154 Plasma kallikrein Human 75 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104046 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429435 CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? LARGKTWCHAEXEF-QDTYANCNSA-N 246249 US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157 Plasma kallikrein Human 10 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104047 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429436 COc1cn(C(CC2CCC2)C(=O)Nc2ccc(cc2)-c2c[nH]c(=O)o2)c(=O)cc1-c1cc(Cl)ccc1C#N 246252 US10183932, Example 158::US9434690, 158::US9822102, Example 158 Plasma kallikrein Human 29 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622778 341104048 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429437 COc1cn(C(C(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H22ClN3O5/c1-14(2)23(24(31)28-18-8-5-15(6-9-18)25(32)33)29-13-21(34-3)20(11-22(29)30)19-10-17(26)7-4-16(19)12-27/h4-11,13-14,23H,1-3H3,(H,28,31)(H,32,33) SGNRWMZAJNVPLX-UHFFFAOYSA-N 246254 US10183932, Example 160::US9434690, 160::US9822102, Example 160 Plasma kallikrein Human 240 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246254&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622781 341104050 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429438 COc1cn(C(C(C)C)C(=O)Nc2ccc3nc([nH]c3c2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N 246256 US10183932, Example 162::US9434690, 162::US9822102, Example 162 Plasma kallikrein Human 250 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246256&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622907 341104052 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429439 COCCC(C(=O)Nc1ccc2c(c1)[nH][nH]c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H20ClN5O5/c1-35-8-7-21(25(34)28-16-5-6-17-20(10-16)29-30-24(17)33)31-13-22(36-2)19(11-23(31)32)18-9-15(26)4-3-14(18)12-27/h3-6,9-11,13,21H,7-8H2,1-2H3,(H,28,34) LSOXVFXTZIMGBB-UHFFFAOYSA-N 246258 US10183932, Example 164::US9434690, 164::US9822102, Example 164 Plasma kallikrein Human 1.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246258&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626913 341104054 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429440 COCCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246260 US10183932, Example 166::US9434690, 166::US9822102, Example 166 Plasma kallikrein Human 6.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246260&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626915 341104056 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429441 COCCC(C(=O)Nc1ccc2cc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246262 US10183932, Example 168::US9434690, 168::US9822102, Example 168 Plasma kallikrein Human 3.1 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246262&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622955 341104058 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429442 CC(C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H21Cl2N3O4/c1-14(2)9-22(24(32)29-18-7-4-15(5-8-18)25(33)34)30-13-21(27)20(11-23(30)31)19-10-17(26)6-3-16(19)12-28/h3-8,10-11,13-14,22H,9H2,1-2H3,(H,29,32)(H,33,34) AMIQZUOXODCISO-UHFFFAOYSA-N 246264 US10183932, Example 170::US9434690, 170::US9822102, Example 170 Plasma kallikrein Human 670 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246264&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622957 341104060 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429443 COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C26H25ClF2N2O6/c1-14(2)10-20(24(33)30-17-7-4-15(5-8-17)25(34)35)31-13-22(36-3)19(12-23(31)32)18-11-16(27)6-9-21(18)37-26(28)29/h4-9,11-14,20,26H,10H2,1-3H3,(H,30,33)(H,34,35) PONZAFSAZRCPMW-UHFFFAOYSA-N 246266 US10183932, Example 172::US9434690, 172::US9822102, Example 172 Plasma kallikrein Human 360 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246266&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117623021 341104062 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429444 COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F 246268 US10183932, Example 174::US9434690, 174::US9822102, Example 174 Plasma kallikrein Human 28 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246268&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626917 341104064 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429445 COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C25H20ClF5N2O7/c1-38-20-12-33(21(34)11-17(20)16-10-14(26)4-7-19(16)40-24(27)28)18(8-9-39-25(29,30)31)22(35)32-15-5-2-13(3-6-15)23(36)37/h2-7,10-12,18,24H,8-9H2,1H3,(H,32,35)(H,36,37) MQEMRRKVUTYPQR-UHFFFAOYSA-N 246270 US10183932, Example 176::US9434690, 176::US9822102, Example 176 Plasma kallikrein Human 58 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246270&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622904 341104066 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429446 CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-15-6-7-16(24(32)33)19(26)9-15)29-12-21(34-2)18(10-22(29)30)17-8-14(25)5-4-13(17)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33) LRTKHAKNKDKNGN-UHFFFAOYSA-N 246272 US10183932, Example 179::US9434690, 178::US9434690, 179::US9822102, Example 179 Plasma kallikrein Human 33 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622926 341104068 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429447 CCC(C(=O)Nc1ccc(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-19-7-5-13(24(32)33)8-18(19)26)29-12-21(34-2)17(10-22(29)30)16-9-15(25)6-4-14(16)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33) JXWVATDLTXDPIQ-UHFFFAOYSA-N 246274 US10183932, Example 181::US9434690, 180::US9434690, 181::US9822102, Example 181 Plasma kallikrein Human 78 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622633 341104069 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429448 CCC(C(=O)Nc1cc(F)c(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-3-20(23(32)29-19-9-17(26)16(24(33)34)7-18(19)27)30-11-21(35-2)15(8-22(30)31)14-6-13(25)5-4-12(14)10-28/h4-9,11,20H,3H2,1-2H3,(H,29,32)(H,33,34) ZVXCULUAQHRZBD-UHFFFAOYSA-N 246276 US10183932, Example 183::US9434690, 182::US9434690, 183::US9822102, Example 183 Plasma kallikrein Human 130 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622968 341104070 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429449 CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-3-18(23(32)29-17-7-6-14(24(33)34)21(26)22(17)27)30-11-19(35-2)16(9-20(30)31)15-8-13(25)5-4-12(15)10-28/h4-9,11,18H,3H2,1-2H3,(H,29,32)(H,33,34) BSTJIMFCDNVZGR-UHFFFAOYSA-N 246278 US10183932, Example 184::US9434690, 184::US9822102, Example 184 Plasma kallikrein Human 110 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246278&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622631 341104071 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429450 CCC(C(=O)Nc1ccc(cc1)-c1nsc(=O)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246280 US10183932, Example 187::US9434690, 186::US9434690, 187::US9822102, Example 187 Plasma kallikrein Human 31 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626919 341104073 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429451 CCC(C(=O)Nc1ccc(cc1)-c1noc(=S)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246282 US10183932, Example 188::US9434690, 188::US9822102, Example 188 Plasma kallikrein Human 31 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246282&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626920 341104074 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429452 CCC(C(=O)Nc1ccc(cc1)-c1ncon1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H20ClN5O4/c1-3-21(25(33)29-18-8-5-15(6-9-18)24-28-14-35-30-24)31-13-22(34-2)20(11-23(31)32)19-10-17(26)7-4-16(19)12-27/h4-11,13-14,21H,3H2,1-2H3,(H,29,33) JIVAXRBOSDSXCF-UHFFFAOYSA-N 246284 US10183932, Example 190::US9434690, 190::US9822102, Example 190 Plasma kallikrein Human 35 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246284&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117623031 341104076 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429453 CCC(C(=O)Nc1ccc(cc1)-c1nnc([nH]1)C(F)(F)C(F)(F)C(=O)OC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246286 US10183932, Example 192::US9434690, 192::US9822102, Example 192 Plasma kallikrein Human 61 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246286&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622636 341104078 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429454 CCC(C(=O)Nc1cc(F)c2c(c1)[nH][nH]c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H17ClFN5O4/c1-3-19(23(33)28-14-7-17(26)22-18(8-14)29-30-24(22)34)31-11-20(35-2)16(9-21(31)32)15-6-13(25)5-4-12(15)10-27/h4-9,11,19H,3H2,1-2H3,(H,28,33) GKSXPUJAHJCWDQ-UHFFFAOYSA-N 246288 US10183932, Example 194::US9434690, 194::US9822102, Example 194 Plasma kallikrein Human 6.3 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626921 341104080 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429455 CCC(C(=O)Nc1ccc2[nH]nc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246290 US10183932, Example 196::US9434690, 196::US9822102, Example 196 Plasma kallikrein Human 21 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622966 341104082 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429456 COc1cn(C(CC2CCS(=O)(=O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O7S/c1-39-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-40(37,38)11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36) PDHWFIGBHMGYOO-UHFFFAOYSA-N 246292 US10183932, Example 198::US9434690, 198::US9822102, Example 198 Plasma kallikrein Human 39 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246292&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622799 341104084 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429457 OC(=O)c1ccc(NC(=O)C(C[C@@H]2CCCCO2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C27H23Cl2N3O5/c28-18-7-4-17(14-30)21(11-18)22-13-25(33)32(15-23(22)29)24(12-20-3-1-2-10-37-20)26(34)31-19-8-5-16(6-9-19)27(35)36/h4-9,11,13,15,20,24H,1-3,10,12H2,(H,31,34)(H,35,36)/t20-,24?/m0/s1 KBFYCDAOFYYRQQ-QHELBMECSA-N 246296 US10183932, Example 202::US9434690, 202::US9822102, Example 202 Plasma kallikrein Human 82 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246296&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622964 341104086 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429458 COCc1n[nH]c(n1)-c1ccc(NC(=O)C(C)n2ccc(cc2=O)-c2cc(Cl)ccc2C#N)cc1 246098 US9434690, 3::US9822102, Example 3 Plasma kallikrein Human 650 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877955 341103947 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429459 CC(C(=O)Nc1ccc(cc1)-c1c[nH]cn1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246100 US10183932, Example 5::US9434690, 5::US9822102, Example 5 Plasma kallikrein Human 330 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297545 341103949 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429460 CC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H16ClN5O3/c1-14(24(33)27-19-6-3-15(4-7-19)21-12-22(31)29-28-21)30-9-8-16(10-23(30)32)20-11-18(25)5-2-17(20)13-26/h2-12,14H,1H3,(H,27,33) MHOPKDGSPNBRDE-UHFFFAOYSA-N 246102 US10183932, Example 7::US9434690, 7::US9822102, Example 7 Plasma kallikrein Human 220 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626901 341103951 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429461 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H16ClN3O4/c1-13(21(28)25-18-6-3-14(4-7-18)22(29)30)26-9-8-15(10-20(26)27)19-11-17(23)5-2-16(19)12-24/h2-11,13H,1H3,(H,25,28)(H,29,30) IVAMXDIDNRHTRD-UHFFFAOYSA-N 246104 US10183932, Example 9::US9434690, 9::US9822102, Example 9 Plasma kallikrein Human 840 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622737 341103953 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429462 CC(C(=O)Nc1ccc2nc[nH]c2c1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246113 US10183932, Example 18::US9434690, 18::US9822102, Example 18 Plasma kallikrein Human 490 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297342 341103962 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429463 CC(C)C(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N 246117 US10183932, Example 22::US9434690, 22::US9822102, Example 22 Plasma kallikrein Human 595 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622744 341103964 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429464 Clc1ccc(C#N)c(c1)-c1ccn(C(Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2nnn[nH]2)c(=O)c1 246121 US10183932, Example 26::US9434690, 26::US9822102, Example 26 Plasma kallikrein Human 67 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626904 341103968 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429465 OC(=O)c1ccc(NC(=O)C(Cc2cccnc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-19-5-8-22(27(29,30)31)21(14-19)18-9-11-34(24(35)13-18)23(12-16-2-1-10-32-15-16)25(36)33-20-6-3-17(4-7-20)26(37)38/h1-11,13-15,23H,12H2,(H,33,36)(H,37,38) LODANOLKNFDNSD-UHFFFAOYSA-N 246123 US10183932, Example 28::US9434690, 28::US9822102, Example 28 Plasma kallikrein Human 570 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622612 341103970 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429466 OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1 InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38) VOEMZDCOWSMTBH-UHFFFAOYSA-N 246125 US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32 Plasma kallikrein Human 620 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622752 341103972 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429467 OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2Br)cc1 InChI=1S/C26H19BrClN3O4/c27-22-6-3-19(28)15-21(22)18-9-12-31(24(32)14-18)23(13-16-7-10-29-11-8-16)25(33)30-20-4-1-17(2-5-20)26(34)35/h1-12,14-15,23H,13H2,(H,30,33)(H,34,35) NBSDLGUPVWYUGD-UHFFFAOYSA-N 246128 US10183932, Example 33::US9434690, 33::US9822102, Example 33 Plasma kallikrein Human 320 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622617 341103973 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429468 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31) MYLKJUSMRUADNT-UHFFFAOYSA-N 246130 US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37 Plasma kallikrein Human 510 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622690 341103975 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429469 CC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C22H14Cl2FN3O4/c1-11(21(30)27-14-4-5-15(22(31)32)19(25)7-14)28-10-18(24)17(8-20(28)29)16-6-13(23)3-2-12(16)9-26/h2-8,10-11H,1H3,(H,27,30)(H,31,32) IAFAJANRVZTTGY-UHFFFAOYSA-N 246135 US10183932, Example 40::US9434690, 40::US9822102, Example 40 Plasma kallikrein Human 550 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622831 341103978 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429470 CC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H15Cl2N5O3/c1-13(24(34)28-17-6-3-14(4-7-17)21-10-22(32)30-29-21)31-12-20(26)19(9-23(31)33)18-8-16(25)5-2-15(18)11-27/h2-10,12-13H,1H3,(H,28,34) AXABJGPJVKQRBN-UHFFFAOYSA-N 246137 US10183932, Example 42::US9434690, 42::US9822102, Example 42 Plasma kallikrein Human 110 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626905 341103980 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429471 CC(C(=O)Nc1ccc2nc([nH]c2c1)C(F)(F)F)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N 246139 US10183932, Example 44::US9434690, 44::US9822102, Example 44 Plasma kallikrein Human 140 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622619 341103982 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429472 OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34) APZJTXHPPDAWRM-UHFFFAOYSA-N 246140 US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47 Plasma kallikrein Human 150 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622732 341103983 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429473 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31) MPSQYCLTAAEIDL-UHFFFAOYSA-N 246150 US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57 Plasma kallikrein Human 17 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622624 341103991 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429474 COc1cn(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H22ClN3O5/c1-35-23-14-30(24(31)12-21(23)20-11-18(27)7-4-17(20)13-28)22(10-15-2-3-15)25(32)29-19-8-5-16(6-9-19)26(33)34/h4-9,11-12,14-15,22H,2-3,10H2,1H3,(H,29,32)(H,33,34) YEOQEAASRZWJNV-UHFFFAOYSA-N 246154 US10183932, Example 60::US9434690, 59::US9434690, 60::US9822102, Example 60 Plasma kallikrein Human 15.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246154&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622901 341103993 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429475 COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34) PDLAMRDOLIUATC-UHFFFAOYSA-N 246158 US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65 Plasma kallikrein Human 67 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622627 341103996 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429476 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32) HUXWVMXMMHUYLB-UHFFFAOYSA-N 246161 US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140 Plasma kallikrein Human 31 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622754 341103997 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429477 CCC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H20ClN5O4/c1-3-22(26(35)29-18-8-5-15(6-9-18)21-12-24(33)31-30-21)32-14-23(36-2)20(11-25(32)34)19-10-17(27)7-4-16(19)13-28/h4-12,14,22H,3H2,1-2H3,(H,29,35) UBQSSKXXBQWBRF-UHFFFAOYSA-N 246164 US10183932, Example 69::US9434690, 69::US9822102, Example 69 Plasma kallikrein Human 11 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246164&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626907 341103998 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429478 CCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClN5O4/c1-3-20(23(32)27-15-6-7-18-19(9-15)29-24(33)28-18)30-12-21(34-2)17(10-22(30)31)16-8-14(25)5-4-13(16)11-26/h4-10,12,20H,3H2,1-2H3,(H,27,32) MYCQSHUBJLXZMN-UHFFFAOYSA-N 246166 US10183932, Example 71::US9434690, 71::US9822102, Example 71 Plasma kallikrein Human 17 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626909 341104000 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429479 CCC(C(=O)Nc1ccc2nc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246168 US10183932, Example 73::US9434690, 73::US9822102, Example 73 Plasma kallikrein Human 16 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246168&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622919 341104002 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429480 CCC(C(=O)Nc1ccc2[nH]c(cc2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246170 US10183932, Example 75::US9434690, 75::US9822102, Example 75 Plasma kallikrein Human 28 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622951 341104004 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429481 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33) XAYFQGTYMRMPAS-UHFFFAOYSA-N 246171 US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78 Plasma kallikrein Human 4.1 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297748 341104005 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429482 CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1 DYNSAJCVHKUDFF-UEDXYCIISA-N 246174 US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81 Plasma kallikrein Human 7.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877945 341104006 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429483 CO[C@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m1/s1 DYNSAJCVHKUDFF-JGHKVMFLSA-N 246177 US10183932, Example 83::US9434690, 82::US9434690, 83::US9822102, Example 83 Plasma kallikrein Human 15 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877889 341104007 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429484 COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1 AETBCOOBUYAHJM-PPUHSXQSSA-N 246179 US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86 Plasma kallikrein Human 16.5 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622620 341104008 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429485 COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1 AETBCOOBUYAHJM-AJZOCDQUSA-N 246182 US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89 Plasma kallikrein Human 7.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877947 341104009 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429486 COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35) UPJPTNTVAMVKSD-UHFFFAOYSA-N 246185 US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93 Plasma kallikrein Human 54 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297749 341104010 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429487 COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35) UPJPTNTVAMVKSD-UHFFFAOYSA-N 246185 US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93 Plasma kallikrein Human 18 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297749 341104010 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429488 COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36) BMRPDPXXIHCBMO-UHFFFAOYSA-N 246189 US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96 Plasma kallikrein Human 19 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297750 341104011 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429489 COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36) SNVIVXDTJLCEGY-UHFFFAOYSA-N 246192 US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100 Plasma kallikrein Human 15 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622761 341104012 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429490 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Plasma kallikrein Human 5.9 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429491 COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36) WVQIDDPAQZTNTF-UHFFFAOYSA-N 246196 US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105 Plasma kallikrein Human 13 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622618 341104013 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429492 COc1cn(C(CCF)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-34-21-13-29(22(30)11-19(21)18-10-16(25)5-2-15(18)12-27)20(8-9-26)23(31)28-17-6-3-14(4-7-17)24(32)33/h2-7,10-11,13,20H,8-9H2,1H3,(H,28,31)(H,32,33) UUJSOQRGXUGTOX-UHFFFAOYSA-N 246202 US10183932, Example 107::US9434690, 107::US9822102, Example 107 Plasma kallikrein Human 56 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246202&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297751 341104015 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429493 COc1cn(C(CC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H17ClF3N3O5/c1-36-20-12-31(21(32)9-18(20)17-8-15(25)5-2-14(17)11-29)19(10-24(26,27)28)22(33)30-16-6-3-13(4-7-16)23(34)35/h2-9,12,19H,10H2,1H3,(H,30,33)(H,34,35) JTNKIBBMWHFHLA-UHFFFAOYSA-N 246204 US10183932, Example 109::US9434690, 109::US9822102, Example 109 Plasma kallikrein Human 220 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246204&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622628 341104017 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429494 COc1cn(C(CC(C)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H21ClF3N3O5/c1-14(26(28,29)30)9-21(24(35)32-18-7-4-15(5-8-18)25(36)37)33-13-22(38-2)20(11-23(33)34)19-10-17(27)6-3-16(19)12-31/h3-8,10-11,13-14,21H,9H2,1-2H3,(H,32,35)(H,36,37) BHOCMFJOQHDNNX-UHFFFAOYSA-N 246206 US10183932, Example 111::US9434690, 111::US9822102, Example 111 Plasma kallikrein Human 220 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246206&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117623008 341104019 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429495 COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36) PPOMRFJZWPHFPA-UHFFFAOYSA-N 246208 US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115 Plasma kallikrein Human 39 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297949 341104021 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429496 COc1cn(C(CC2(C)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H24ClN3O5/c1-27(9-10-27)13-22(25(33)30-19-7-4-16(5-8-19)26(34)35)31-15-23(36-2)21(12-24(31)32)20-11-18(28)6-3-17(20)14-29/h3-8,11-12,15,22H,9-10,13H2,1-2H3,(H,30,33)(H,34,35) DCFGHORVDDAJPY-UHFFFAOYSA-N 246211 US10183932, Example 116::US9434690, 116::US9822102, Example 116 Plasma kallikrein Human 11 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246211&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622788 341104022 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429497 CCOC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O6/c1-3-34-23(22(30)27-17-8-5-14(6-9-17)24(31)32)28-13-20(33-2)19(11-21(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,23H,3H2,1-2H3,(H,27,30)(H,31,32) MUNUHSGUPNMRDO-UHFFFAOYSA-N 246213 US10183932, Example 118::US9434690, 118::US9822102, Example 118 Plasma kallikrein Human 210 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246213&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117623009 341104024 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429498 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1Br InChI=1S/C22H18BrClN2O5/c1-12(21(28)25-15-6-3-13(4-7-15)22(29)30)26-11-19(31-2)17(10-20(26)27)16-9-14(24)5-8-18(16)23/h3-12H,1-2H3,(H,25,28)(H,29,30) BZZDCJXMIRUBDL-UHFFFAOYSA-N 246216 US10183932, Example 121::US9434690, 121::US9822102, Example 121 Plasma kallikrein Human 220 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246216&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297951 341104027 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429499 COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C(F)(F)F InChI=1S/C23H18ClF3N2O5/c1-12(21(31)28-15-6-3-13(4-7-15)22(32)33)29-11-19(34-2)17(10-20(29)30)16-9-14(24)5-8-18(16)23(25,26)27/h3-12H,1-2H3,(H,28,31)(H,32,33) AHLPDNRPHFMHAO-UHFFFAOYSA-N 246218 US10183932, Example 123::US9434690, 123::US9822102, Example 123 Plasma kallikrein Human 1100 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246218&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622932 341104029 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429500 COc1cn(C(CCO)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C24H20ClN3O6/c1-34-21-13-28(22(30)11-19(21)18-10-16(25)5-2-15(18)12-26)20(8-9-29)23(31)27-17-6-3-14(4-7-17)24(32)33/h2-7,10-11,13,20,29H,8-9H2,1H3,(H,27,31)(H,32,33) BKTRHZIMQRNWEQ-UHFFFAOYSA-N 246221 US10183932, Example 126::US9434690, 126::US9822102, Example 126 Plasma kallikrein Human 64 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246221&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622878 341104032 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429501 CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F InChI=1S/C24H21ClF2N2O6/c1-3-18(22(31)28-15-7-4-13(5-8-15)23(32)33)29-12-20(34-2)17(11-21(29)30)16-10-14(25)6-9-19(16)35-24(26)27/h4-12,18,24H,3H2,1-2H3,(H,28,31)(H,32,33) BGDFMSJIOCVRBT-UHFFFAOYSA-N 246223 US10183932, Example 128::US9434690, 128::US9822102, Example 128 Plasma kallikrein Human 180 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246223&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622790 341104034 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429502 CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC(F)F)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C23H16ClF2N3O5/c1-12(21(31)28-16-6-3-13(4-7-16)22(32)33)29-11-19(34-23(25)26)18(9-20(29)30)17-8-15(24)5-2-14(17)10-27/h2-9,11-12,23H,1H3,(H,28,31)(H,32,33) XEVLNKRJTMYBIC-UHFFFAOYSA-N 246225 US10183932, Example 130::US9434690, 130::US9822102, Example 130 Plasma kallikrein Human 1300 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246225&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622897 341104036 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429503 COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38) CJNBXUGWBBVSDD-UHFFFAOYSA-N 246227 US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135 Plasma kallikrein Human 5.8 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86298154 341104038 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429504 COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36) YNXCWDXRPDZZLO-UHFFFAOYSA-N 246231 US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138 Plasma kallikrein Human 9.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622873 341104039 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429505 CCC1(CC(C(=O)Nc2ccc(cc2)-c2noc(=O)[nH]2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)COC1 246234 US10183932, Example 139::US9434690, 139::US9822102, Example 139 Plasma kallikrein Human 9.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246234&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626910 341104040 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429506 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Plasma kallikrein Human 1600 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429507 CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35) NWTLKQWFPQKMLC-UHFFFAOYSA-N 246220 US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144 Plasma kallikrein Human 4.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86297952 341104031 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429508 COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38) PNSIVGGUCOLACI-UHFFFAOYSA-N 246239 US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147 Plasma kallikrein Human 98 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86298155 341104041 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429509 COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38) PNSIVGGUCOLACI-UHFFFAOYSA-N 246239 US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147 Plasma kallikrein Human 70 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 86298155 341104041 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429510 COc1cn(C(CC2CC(F)(F)C2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C27H22ClF2N3O5/c1-38-23-14-33(24(34)10-21(23)20-9-18(28)5-2-17(20)13-31)22(8-15-11-27(29,30)12-15)25(35)32-19-6-3-16(4-7-19)26(36)37/h2-7,9-10,14-15,22H,8,11-12H2,1H3,(H,32,35)(H,36,37) IIHVYKJYWMUBJC-UHFFFAOYSA-N 246243 US10183932, Example 149::US9434690, 149::US9822102, Example 149 Plasma kallikrein Human 27 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246243&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622900 341104043 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429511 COc1cn(C(CC2(C)CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C29H28ClN3O6/c1-29(9-11-39-12-10-29)15-24(27(35)32-21-7-4-18(5-8-21)28(36)37)33-17-25(38-2)23(14-26(33)34)22-13-20(30)6-3-19(22)16-31/h3-8,13-14,17,24H,9-12,15H2,1-2H3,(H,32,35)(H,36,37) PAESNLCGOZMSMT-UHFFFAOYSA-N 246245 US10183932, Example 151::US9434690, 151::US9822102, Example 151 Plasma kallikrein Human 110 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246245&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117623020 341104045 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429512 CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26? LARGKTWCHAEXEF-CIGLETDBSA-N 246246 US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154 Plasma kallikrein Human 45 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104046 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429513 CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? LARGKTWCHAEXEF-QDTYANCNSA-N 246249 US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157 Plasma kallikrein Human 5.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622774 341104047 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429514 COc1cn(C(CC2CCC2)C(=O)Nc2ccc3c(c2)[nH]n(C)c3=O)c(=O)cc1-c1cc(Cl)ccc1C#N 246253 US10183932, Example 159::US9434690, 159::US9822102, Example 159 Plasma kallikrein Human 16 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246253&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626911 341104049 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429515 COc1cn(C(C(C)C)C(=O)Nc2ccc(C(O)=O)c(C)c2)c(=O)cc1-c1cc(Cl)ccc1C#N InChI=1S/C26H24ClN3O5/c1-14(2)24(25(32)29-18-7-8-19(26(33)34)15(3)9-18)30-13-22(35-4)21(11-23(30)31)20-10-17(27)6-5-16(20)12-28/h5-11,13-14,24H,1-4H3,(H,29,32)(H,33,34) ZYWDBAHJEMNANX-UHFFFAOYSA-N 246255 US10183932, Example 161::US9434690, 161::US9822102, Example 161 Plasma kallikrein Human 1500 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246255&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622965 341104051 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429516 COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C25H20ClN5O5/c1-35-8-7-21(24(33)28-16-5-6-19-20(10-16)30-25(34)29-19)31-13-22(36-2)18(11-23(31)32)17-9-15(26)4-3-14(17)12-27/h3-6,9-11,13,21H,7-8H2,1-2H3,(H,28,33) LVYGLUYPTDVDIW-UHFFFAOYSA-N 246257 US10183932, Example 163::US9434690, 163::US9822102, Example 163 Plasma kallikrein Human 3.6 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626912 341104053 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429517 COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246259 US10183932, Example 165::US9434690, 165::US9822102, Example 165 Plasma kallikrein Human 8.2 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246259&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626914 341104055 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429518 COCCC(C(=O)Nc1ccc2[nH]nc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246261 US10183932, Example 167::US9434690, 167::US9822102, Example 167 Plasma kallikrein Human 8.4 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626916 341104057 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429519 COCCC(C(=O)Nc1cc2[nH]c(cc2cc1OC)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246263 US10183932, Example 169::US9434690, 169::US9822102, Example 169 Plasma kallikrein Human 54 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246263&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622918 341104059 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429520 OC(=O)c1ccc(NC(=O)C(CCOC(F)(F)F)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1 InChI=1S/C24H16Cl2F3N3O5/c25-15-4-1-14(11-30)17(9-15)18-10-21(33)32(12-19(18)26)20(7-8-37-24(27,28)29)22(34)31-16-5-2-13(3-6-16)23(35)36/h1-6,9-10,12,20H,7-8H2,(H,31,34)(H,35,36) AHPKGYGFEFPFAF-UHFFFAOYSA-N 246265 US10183932, Example 171::US9434690, 171::US9822102, Example 171 Plasma kallikrein Human 89 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246265&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622783 341104061 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429521 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F InChI=1S/C25H23ClF2N2O7/c1-35-10-9-19(23(32)29-16-6-3-14(4-7-16)24(33)34)30-13-21(36-2)18(12-22(30)31)17-11-15(26)5-8-20(17)37-25(27)28/h3-8,11-13,19,25H,9-10H2,1-2H3,(H,29,32)(H,33,34) BRLSWNMQGWOZIZ-UHFFFAOYSA-N 246267 US10183932, Example 173::US9434690, 173::US9822102, Example 173 Plasma kallikrein Human 54 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246267&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622938 341104063 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429522 COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F InChI=1S/C25H21ClF2N4O6/c1-36-8-7-19(23(34)29-14-4-5-17-18(10-14)31-25(35)30-17)32-12-21(37-2)16(11-22(32)33)15-9-13(26)3-6-20(15)38-24(27)28/h3-6,9-12,19,24H,7-8H2,1-2H3,(H,29,34) NKCAKTVAUQJXMR-UHFFFAOYSA-N 246269 US10183932, Example 175::US9434690, 175::US9822102, Example 175 Plasma kallikrein Human 20 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246269&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626918 341104065 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429523 COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m1/s1 OTYWURKUSAPCDC-LCQOSCCDSA-N 246271 US10183932, Example 177::US9434690, 177::US9822102, Example 177 Plasma kallikrein Human 120 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246271&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622940 341104067 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429524 CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-15-6-7-16(24(32)33)19(26)9-15)29-12-21(34-2)18(10-22(29)30)17-8-14(25)5-4-13(17)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33) LRTKHAKNKDKNGN-UHFFFAOYSA-N 246272 US10183932, Example 179::US9434690, 178::US9434690, 179::US9822102, Example 179 Plasma kallikrein Human 24 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622926 341104068 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429525 CCC(C(=O)Nc1ccc(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-19-7-5-13(24(32)33)8-18(19)26)29-12-21(34-2)17(10-22(29)30)16-9-15(25)6-4-14(16)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33) JXWVATDLTXDPIQ-UHFFFAOYSA-N 246274 US10183932, Example 181::US9434690, 180::US9434690, 181::US9822102, Example 181 Plasma kallikrein Human 45 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622633 341104069 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429526 CCC(C(=O)Nc1cc(F)c(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-3-20(23(32)29-19-9-17(26)16(24(33)34)7-18(19)27)30-11-21(35-2)15(8-22(30)31)14-6-13(25)5-4-12(14)10-28/h4-9,11,20H,3H2,1-2H3,(H,29,32)(H,33,34) ZVXCULUAQHRZBD-UHFFFAOYSA-N 246276 US10183932, Example 183::US9434690, 182::US9434690, 183::US9822102, Example 183 Plasma kallikrein Human 62 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622968 341104070 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429527 CCC(C(=O)Nc1cc(F)c(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H18ClF2N3O5/c1-3-19(23(32)29-14-7-17(26)22(24(33)34)18(27)8-14)30-11-20(35-2)16(9-21(30)31)15-6-13(25)5-4-12(15)10-28/h4-9,11,19H,3H2,1-2H3,(H,29,32)(H,33,34) UALXRLIAFKMVEE-UHFFFAOYSA-N 246279 US10183932, Example 185::US9434690, 185::US9822102, Example 185 Plasma kallikrein Human 40 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246279&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622950 341104072 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429528 CCC(C(=O)Nc1ccc(cc1)-c1nsc(=O)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246280 US10183932, Example 187::US9434690, 186::US9434690, 187::US9822102, Example 187 Plasma kallikrein Human 14 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 129626919 341104073 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429529 CCC(C(=O)Nc1ccc(cc1)-c1ncco1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H21ClN4O4/c1-3-22(25(33)30-19-8-5-16(6-9-19)26-29-10-11-35-26)31-15-23(34-2)21(13-24(31)32)20-12-18(27)7-4-17(20)14-28/h4-13,15,22H,3H2,1-2H3,(H,30,33) WOVKYOZMJFJOLI-UHFFFAOYSA-N 246283 US10183932, Example 189::US9434690, 189::US9822102, Example 189 Plasma kallikrein Human 63 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622969 341104075 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429530 CCC(C(=O)Nc1ccc(cc1)-c1nnc(C)o1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C26H22ClN5O4/c1-4-22(25(34)29-19-9-6-16(7-10-19)26-31-30-15(2)36-26)32-14-23(35-3)21(12-24(32)33)20-11-18(27)8-5-17(20)13-28/h5-12,14,22H,4H2,1-3H3,(H,29,34) IWJPZYSOUYLTNJ-UHFFFAOYSA-N 246285 US10183932, Example 191::US9434690, 191::US9822102, Example 191 Plasma kallikrein Human 35 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246285&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622798 341104077 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429531 CCC(C(=O)Nc1ccc(cc1)-c1nnc([nH]1)C(F)(F)C(F)(F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246287 US10183932, Example 193::US9434690, 193::US9822102, Example 193 Plasma kallikrein Human 46 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622923 341104079 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429532 CCC(C(=O)Nc1ccc2c(n[nH]c2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246289 US10183932, Example 195::US9434690, 195::US9822102, Example 195 Plasma kallikrein Human 59 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118877926 341104081 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429533 CCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N 246291 US10183932, Example 197::US9434690, 197::US9822102, Example 197 Plasma kallikrein Human 10 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622970 341104083 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429534 COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1 OTYWURKUSAPCDC-YDNXMHBPSA-N 246293 US10183932, Example 199::US9434690, 199::US9822102, Example 199 Plasma kallikrein Human 34 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246293&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622782 341104085 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 429535 COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N InChI=1S/C24H19Cl2N3O5/c1-34-9-8-21(23(31)28-17-6-3-14(4-7-17)24(32)33)29-13-20(26)19(11-22(29)30)18-10-16(25)5-2-15(18)12-27/h2-7,10-11,13,21H,8-9H2,1H3,(H,28,31)(H,32,33) YWIBKDIZKZBHGC-UHFFFAOYSA-N 246299 US10183932, Example 205::US9434690, 205::US9822102, Example 205 Plasma kallikrein Human 68 7.4 25.00 C US Patent 10.7270/Q2K936FF aid1803376 US9434690 Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ 9/6/2016 8/28/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246299&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117622796 341104087 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3